<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32547364</article-id>
<article-id pub-id-type="pmc">7274346</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2020.00079</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Zhiqi</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Yanfeng</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Wei</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ling</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Hua</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Pin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Yajin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Wenjie</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Yunlin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Chuan</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/237744/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, Comparative Medicine Center, Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Michele Papa, University of Campania Luigi Vanvitelli, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ursula Wyneken, University of the Andes, Chile, Chile; Minho Moon, Konyang University, South Korea; Esperanza González, CIC bioGUNE, Spain</p>
</fn>
<corresp id="c001">*Correspondence: Chuan Qin, <email>qinchuan@pumc.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>13</volume>
<elocation-id>79</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Song, Xu, Deng, Zhang, Zhu, Yu, Qu, Zhao, Han and Qin.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Song, Xu, Deng, Zhang, Zhu, Yu, Qu, Zhao, Han and Qin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Brain derived exosomes (BDEs) are extracellular nanovesicles that are collectively released by all cell lineages of the central nervous system and contain cargo from their original cells. They are emerging as key mediators of communication and waste management among neurons, glial cells and connective tissue during both physiological and pathological conditions in the brain. We review the rapidly growing frontier of BDEs biology in recent years including the involvement of exosomes in neuronal development, maintenance and communication through their multiple signaling functions. Particularly, we highlight the important role of exosomes in Alzheimer’s disease (AD), both as a pathogenic agent and as a disease biomarker. Our understanding of such unique nanovesicles may offer not only answers about the (patho) physiological course in AD and associated neurodegenerative diseases but also ideal methods to develop these vesicles as vehicles for drug delivery or as tools to monitor brain diseases in a non-invasive manner because crossing the blood brain barrier is an inherent capability of exosomes. BDEs have potential as biomarkers and as therapeutic tools for AD and related brain disorders in the near future.</p>
</abstract>
<kwd-group>
<kwd>brain derived exosomes</kwd>
<kwd>Alzheimer’s disease</kwd>
<kwd>cell-to-cell communication</kwd>
<kwd>biomarker</kwd>
<kwd>extracellular vesicles</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="206"></ref-count>
<page-count count="17"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Exosomes are small extracellular nano-sized vesicles between 30 and 150 nm in diameter (<xref ref-type="bibr" rid="B39">DeLeo and Ikezu, 2018</xref>) that were first described in the 1980s (<xref ref-type="bibr" rid="B82">Johnstone et al., 1987</xref>). They consist of one type of EVs and are categorized on the basis of their biogenesis pathways (<xref ref-type="bibr" rid="B129">Pan and Johnstone, 1983</xref>). Since then, exosomes have been isolated from nearly all mammalian cell types, including cells in the CNS such as neurons, astrocytes, oligodendrocytes, microglia, and Schwann cells, as well as endothelial cells (<xref ref-type="bibr" rid="B49">Faure et al., 2006</xref>; <xref ref-type="bibr" rid="B154">Sharma et al., 2013</xref>). Exosomes released from the nervous system are collectively called BDEs.</p>
<p>To form MVBs with ILVs, early endosomes undergo inward budding (<xref ref-type="bibr" rid="B31">Colombo et al., 2014</xref>). Then, ILVs are released into the extracellular environment as exosomes via fusion of MVBs with the plasma membrane (<xref ref-type="bibr" rid="B73">Heijnen et al., 1999</xref>; <xref ref-type="bibr" rid="B123">Mulcahy et al., 2014</xref>). Alternatively, exosomal formation can be regulated by sphingolipids, ceramides and tetraspanins (<xref ref-type="bibr" rid="B166">Trajkovic et al., 2008</xref>; <xref ref-type="bibr" rid="B161">Stuffers et al., 2009</xref>; <xref ref-type="bibr" rid="B173">van Niel et al., 2011</xref>). Otherwise, MVBs can fuse with the lysosomal membrane, resulting in degradation of ILVs and recycling of their content (<xref ref-type="bibr" rid="B161">Stuffers et al., 2009</xref>; <xref ref-type="bibr" rid="B94">Klumperman and Raposo, 2014</xref>). As a result of their origin and multifarious molecular cargo, including but not limited to gDNA, mRNA, other non-coding RNAs, lipids and proteins (<xref ref-type="bibr" rid="B195">Yokoi et al., 2019</xref>), the molecular species and relative amounts in exosomes are highly heterogeneous and complex in composition. Exosomes can randomly or selectively exhibit great variety depending on their membranes, cytosolic proteins, and nucleic acids compared with the cells that release them. Based on the proteomic and other comprehensive analyses, the heterogeneity of exosomes is conceptualized on the basis of their size, content (cargo), functional impact on recipient cells and cell of origin (source) (<xref ref-type="bibr" rid="B84">Kalluri and LeBleu, 2020</xref>). It is becoming increasingly clear that exosomes have specialized functions and play a key role in coagulation, intercellular signaling and waste management (<xref ref-type="bibr" rid="B171">van der Pol et al., 2012</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Biogenesis and cell-to-cell communication of extracellular vesicles (EV), especially exosomes. Exosomes are formed by the inward budding of the multivesicular body (MVB) membrane, which is formed by invagination of the endosomal membrane. Early endosomes go through transition to late endosomes and are further burdened to form late MVBs containing intraluminal vesicles (ILVs) (<xref ref-type="bibr" rid="B31">Colombo et al., 2014</xref>). Cargo sorting into exosomes involves the endosomal sorting complex required for transport (ESCRT)-dependent mechanism, which are managed by ESCRT proteins (ESCRT-0, I, II, and III) and their accessories (ALIX, TSG101, and VPS32) (<xref ref-type="bibr" rid="B77">Hurley, 2010</xref>; <xref ref-type="bibr" rid="B174">van Niel et al., 2018</xref>), and ESCRT-independent mechanism, which are mediated by neutral sphingomyelinase 2 (nSMaseII), tetraspanins, and the chaperone heat shock proteins (HSP70 and HSC70), can develop ILVs (<xref ref-type="bibr" rid="B114">Malla et al., 2018</xref>). ILVs have two fates, either fusing with the lysosome resulting in the degradation of the ILVs and their contents for recycling as an endolysosomal pathway (<xref ref-type="bibr" rid="B94">Klumperman and Raposo, 2014</xref>), or fusing with the plasma membrane where they are released into the extracellular space as exosomes through a secretory pathway (<xref ref-type="bibr" rid="B73">Heijnen et al., 1999</xref>). Microvesicles are formed directly by outward budding of the plasma membrane, a course which is managed by the ESCRT components and ADP ribosylation factor 6 (ARF6), some small GTPases, lipids, and Ca<sup>2+</sup>-dependent enzymatic machineries (<xref ref-type="bibr" rid="B164">Thompson et al., 2016</xref>). Apoptotic bodies are the largest of the EVs. They “bleb” off the cell membrane and contain material from cells undergoing apoptosis, which are typically engulfed by macrophages (<xref ref-type="bibr" rid="B164">Thompson et al., 2016</xref>). After release into the extracellular space, exosomes can be internalized by recipient cells mediated by the interaction of various exosomal surface proteins and cellular receptors via several mechanisms including phagocytosis, plasma membrane fusion, macropinocytosis and endocytosis (<xref ref-type="bibr" rid="B117">McKelvey et al., 2015</xref>). The contents of exosomes can effectively influence cellular processes through taking part in genetic/protein transfer, transcriptional regulation or post-transcriptional regulation. Alternatively, exosomes can be further fused with the lysosomes for degradation (<xref ref-type="bibr" rid="B143">Saeedi et al., 2019</xref>; <xref ref-type="bibr" rid="B196">You and Ikezu, 2019</xref>).</p>
</caption>
<graphic xlink:href="fnmol-13-00079-g001"></graphic>
</fig>
<p>During the formation process, exosomes are comprised of enriched endosome-associated components such as flotillins and annexins (<xref ref-type="bibr" rid="B175">van Niel et al., 2006</xref>), ALIX, the ESCRT component, tumor susceptibility gene 101 protein (TSG101) (<xref ref-type="bibr" rid="B110">Lotvall et al., 2014</xref>) and lipid rafts, including cholesterol, sphingomyelin and ceramide (<xref ref-type="bibr" rid="B39">DeLeo and Ikezu, 2018</xref>). Moreover, membrane proteins, including tetraspanins such as abundant CD9, CD63, and CD81, that are considered as markers for exosomes and play important roles in the biogenesis of endosomes or MVBs (<xref ref-type="bibr" rid="B110">Lotvall et al., 2014</xref>; <xref ref-type="bibr" rid="B96">Kowal et al., 2016</xref>). Depending on the cell type from which they are secreted, exosome vesicles themselves also hold particular and varied types of markers that contribute to identifying their origins (<xref ref-type="bibr" rid="B110">Lotvall et al., 2014</xref>; <xref ref-type="bibr" rid="B96">Kowal et al., 2016</xref>). For example, neuronal L1 cell adhesion molecule (L1CAM) can be used as a biomarker for isolating BDEs (<xref ref-type="bibr" rid="B28">Cicognola et al., 2019</xref>).</p>
<p>Once the exosomes are secreted, they can be internalized from the extracellular space by recipient cells through several mechanisms including phagocytosis, micropinocytosis, endocytosis, and plasma membrane fusion (<xref ref-type="bibr" rid="B117">McKelvey et al., 2015</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>). On the other hand, exosomes carrying multiple cargo with valuable biological information can also be released into most bodily fluids such as plasma, cerebrospinal fluid, urine, saliva, amniotic fluid, colostrum, breast milk, synovial fluid, semen and pleural ascites, not only in normal tissues (<xref ref-type="bibr" rid="B32">Corrado et al., 2013</xref>; <xref ref-type="bibr" rid="B117">McKelvey et al., 2015</xref>) but also in aberrant bodies such as tumors (<xref ref-type="bibr" rid="B20">Camussi et al., 2011</xref>; <xref ref-type="bibr" rid="B141">Rak and Guha, 2012</xref>). For the above reasons, exosomes play key roles in the management of normal physiological environments, such as immune surveillance (<xref ref-type="bibr" rid="B140">Rajendran et al., 2006</xref>), stem cell maintenance (<xref ref-type="bibr" rid="B142">Ratajczak et al., 2006</xref>), tissue repair (<xref ref-type="bibr" rid="B54">Gatti et al., 2011</xref>), and blood coagulation (<xref ref-type="bibr" rid="B38">Del et al., 2005</xref>), as well as in the pathological processes associated with several diseases (<xref ref-type="bibr" rid="B108">Liu et al., 2019</xref>), including neurodegenerative diseases such as AD (<xref ref-type="bibr" rid="B13">Bellingham et al., 2012</xref>; <xref ref-type="bibr" rid="B179">Watson et al., 2019</xref>) and PD (<xref ref-type="bibr" rid="B48">Emmanouilidou et al., 2010</xref>).</p>
<p>Given the characteristic described above, exosomes and their constituents represent a novel class of therapeutic targets and such features also give them advantages as biomarkers to distinguish healthy and disease states (<xref ref-type="bibr" rid="B48">Emmanouilidou et al., 2010</xref>) and for prognosis prediction and therapy for diseases. Moreover, recent studies have demonstrated that exosomes may also be directly considered as potential therapeutic agents. For instance, mesenchymal stem cell-derived exosomes have been used in tissue regeneration (<xref ref-type="bibr" rid="B100">Lai et al., 2011</xref>; <xref ref-type="bibr" rid="B165">Timmers et al., 2011</xref>) and tumor antigen-pulsed dendritic cell-derived exosomes have been developed for cancer immune response modulation (<xref ref-type="bibr" rid="B206">Zitvogel et al., 1998</xref>). Remarkably, exosomes have an efficient capability to cross the BBB (<xref ref-type="bibr" rid="B21">Chen et al., 2016</xref>). In particular, exosomes isolated from CSF are rich in proteins that originate from the brain such as neuron-specific markers, microglial markers (CD11b and CD45) and Apo-E (<xref ref-type="bibr" rid="B25">Chiasserini et al., 2014</xref>), making them potential novel drug delivery vehicles for treating nervous system diseases. Here, we mainly discuss and summarize the role of BDEs in normal biological processes in the CNS as well as the aberrant pathological state of AD and focus on explaining how exosomes can be targeted or directly exploited as biomarkers or therapeutics in AD.</p>
</sec>
<sec id="S2">
<title>Physiological Roles of BDEs in the CNS</title>
<p>Exosomes exert their effects on essential biological processes throughout the body including the CNS by different mechanisms. These mechanisms include cell surface receptors activation through direct binding to lipid ligands and proteins, exosomal membrane fusion contents with the recipient cell plasma membrane and effectors delivery. Some of these effectors are oncogenes, transcription factors, small and large non-coding regulatory RNAs (such as miRNAs) and mRNAs, as well as infectious particles such as amyloid-β (Aβ)−derived (<xref ref-type="bibr" rid="B13">Bellingham et al., 2012</xref>) and α-synuclein (<xref ref-type="bibr" rid="B48">Emmanouilidou et al., 2010</xref>) into recipient cells (<xref ref-type="bibr" rid="B20">Camussi et al., 2011</xref>; <xref ref-type="bibr" rid="B105">Lee et al., 2012</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>). In this manner, exosomes participate in the maintenance of normal physiology (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Intercellular communication of BDEs in the CNS in (patho) physiological course in AD. Exosomes secreted from oligodendrocytes, microglia, astrocytes and mesenchymal stem cells includes host cell derived cytosolic proteins, cytokines and transcription factors, Aβ scavenger enzymes, Aβ (<xref ref-type="bibr" rid="B143">Saeedi et al., 2019</xref>; <xref ref-type="bibr" rid="B196">You and Ikezu, 2019</xref>) and tau protein (<xref ref-type="bibr" rid="B39">DeLeo and Ikezu, 2018</xref>) along with nucleic acids (DNA, mRNA, miRNA and/or lncRNA and/or cirRNA) (<xref ref-type="bibr" rid="B20">Camussi et al., 2011</xref>; <xref ref-type="bibr" rid="B105">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="B195">Yokoi et al., 2019</xref>). They afford positive as well as negative effect on the neurons depending on the cargo they carry. In the physiological condition, exosomes benefit to the reciprocal communication between neural cells (e.g., neuron-glia interaction), synaptic plasticity, neuronal development and neuroimmune communication. In the early stage of AD, the microglia activation by Aβ has neuroprotective effect because it induces phagocytosis and Aβ clearance (<xref ref-type="bibr" rid="B15">Bolmont et al., 2008</xref>; <xref ref-type="bibr" rid="B75">Hickman et al., 2008</xref>). The microglia stimulation by astrocyte released ATP induces the secretion of exosomes including P2X7 receptor as a defensive strategy to escape astrocyte signaling (<xref ref-type="bibr" rid="B15">Bolmont et al., 2008</xref>; <xref ref-type="bibr" rid="B75">Hickman et al., 2008</xref>). In the latter stage of AD, microglia secrete exosomes containing pro-IL1β, active caspase-1 and soluble toxic Aβ that have detrimental effects on neurons (<xref ref-type="bibr" rid="B14">Bianco et al., 2005</xref>; <xref ref-type="bibr" rid="B168">Trotta et al., 2018</xref>). Neurodegenerative associated proteins such as Aβ, Tau, prions (<xref ref-type="bibr" rid="B49">Faure et al., 2006</xref>) and α-synuclein (<xref ref-type="bibr" rid="B48">Emmanouilidou et al., 2010</xref>) can also be derived from neural derived exosomes, leading to the spread of protein aggregate seeds and disease progression. In addition, these exosomes could be exported via blood-brain barrier as circulatory EVs, which can be used for disease-specific biomarkers, even future for therapeutic researches (<xref ref-type="bibr" rid="B164">Thompson et al., 2016</xref>).</p>
</caption>
<graphic xlink:href="fnmol-13-00079-g002"></graphic>
</fig>
<p>Particularly, in the CNS, exosomes can be released from virtually all cell types, including various types of neurons, astrocytes, oligodendrocytes, microglia, and Schwann cells, as well as endothelial cells (<xref ref-type="bibr" rid="B49">Faure et al., 2006</xref>; <xref ref-type="bibr" rid="B154">Sharma et al., 2013</xref>). EVs carry and release multiple molecules related to neuronal function and neurotransmission in the brain, which is beneficial for the reciprocal communication between neural cells (e.g., neuron−glia interactions), synaptic plasticity, neuronal development, and neuroimmune communication (<xref ref-type="bibr" rid="B52">Fruhbeis et al., 2013a</xref>; <xref ref-type="bibr" rid="B139">Rajendran et al., 2014</xref>; <xref ref-type="bibr" rid="B78">Iraci et al., 2016</xref>; <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Exosome is a double-edged sword in nervous system.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Condition</bold>
</td>
<td align="center" colspan="2" rowspan="1" valign="top">
<bold>Function</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Physiological roles</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuron−glia communication</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuron and microglia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B53">Fruhbeis et al., 2013b</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuron and astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B118">Men et al., 2019</xref>; <xref ref-type="bibr" rid="B130">Pascua-Maestro et al., 2019</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuron and oligodendrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B97">Kramer-Albers et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pathological roles in AD</td>
<td align="center" colspan="2" rowspan="1" valign="top">Synaptic plasticity and neurotransmission</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B26">Chivet et al., 2012</xref>; <xref ref-type="bibr" rid="B95">Koniusz et al., 2016</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">Enhancement of neuron protection</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B66">Guitart et al., 2016</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">Improvement neuronal development</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B44">Drago et al., 2017</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">Carry the two hallmarks of AD brains, Aβ, and hyperphosphorylated tau</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B148">Sardar et al., 2018</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">The spread of oligomers and neurotoxicity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B69">Hamlett et al., 2018</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">Carry the synaptic proteins</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B62">Goetzl et al., 2016a</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">Carry the ceramide and sphingosine-1-phosphate (S1P)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B199">Yuyama et al., 2012</xref>; <xref ref-type="bibr" rid="B42">Dinkins et al., 2014</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="2" rowspan="1" valign="top">Containing tyrosine phosphorylated insulin receptor substrate 1 (IRS1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B86">Kapogiannis et al., 2015</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="S2.SS1">
<title>Neuron-Glia Communication via Exosome Secretion</title>
<p>Neurons and glial cells (a class of cells that mainly includes microglia, astrocytes, and oligodendrocytes) orchestrate CNS homeostasis via numerous mechanisms of intercellular communication. Exosomes might regulate the physiological condition of the recipient cells and interactions between various neural cells. For example, upon activation of glutamatergic synapses, cortical neuron-derived exosomes are selectively delivered to neurons but not glial cells (<xref ref-type="bibr" rid="B95">Koniusz et al., 2016</xref>). Recent studies using CD63-GFP positive intraluminal vesicles as exosomal reporter in mice have demonstrated that exosomes participate in mediating neuron to astroglia communication in the CNS (<xref ref-type="bibr" rid="B118">Men et al., 2019</xref>). Furthermore, miRNAs (especially miR-124a) in exosomes isolated from neuron-conditioned medium possess excitatory amino acid transporter 2, a necessary mediator of glutamate uptake via the internalization of exosomes into astrocytes (<xref ref-type="bibr" rid="B121">Morel et al., 2013</xref>). However, exosomes also participate in reciprocal oligodendrocyte-neuron communication and transfer cargo from oligodendrocytes to neurons (<xref ref-type="bibr" rid="B52">Fruhbeis et al., 2013a</xref>). Although exosome-mediated communication and the manner by which exosomes select their recipient cells are largely unclear, emerging evidence suggests that exosomes serve as selectively important conveyers for neuron-neuron or neuron-glia interaction in the brain by transmitting genetic information, various bioactive proteins, and lipids.</p>
</sec>
<sec id="S2.SS2">
<title>Synaptic Plasticity and Neurotransmission by the Release of Exosomes</title>
<p>Maintenance and improvement of synaptic connectivity in the adult brain are crucial for cognitive function. Neural synaptic plasticity is mediated not only by neuron-specific progression but also by glial cells, such as astrocytes and microglia (<xref ref-type="bibr" rid="B122">Morris et al., 2013</xref>). Under resting conditions, synaptic vesicles are reposited in the cytoplasm of the nerve terminal. Many synaptic vesicles stick on some specialized sites at the presynaptic plasma membrane named active zones. During incoming action potentials, exocytosis of synaptic vesicles confirm how much transmitter is released from nerve terminals (<xref ref-type="bibr" rid="B79">Jahn and Fasshauer, 2012</xref>). In addition to typical synaptic neurotransmission, signal transduction of neurons via the secretion of exosomes can induce a range of neurobiological functions including synaptic plasticity (<xref ref-type="bibr" rid="B26">Chivet et al., 2012</xref>; <xref ref-type="bibr" rid="B95">Koniusz et al., 2016</xref>). During management of synaptic plasticity, PC12 cell-derived exosomes can stimulate synaptic pruning through enhancement of the complement component 3 level in microglial MG6 cells (<xref ref-type="bibr" rid="B11">Bahrini et al., 2015</xref>). For instance, enhanced secretion of cortical neuron-derived exosomes containing neurotransmitter receptors leads to increased glutamatergic activity (<xref ref-type="bibr" rid="B99">Lachenal et al., 2011</xref>). Additionally, by managing the number of AMPA receptors for glutamate transmission, neuronal-derived exosomes might affect synaptic plasticity (<xref ref-type="bibr" rid="B99">Lachenal et al., 2011</xref>).</p>
</sec>
<sec id="S2.SS3">
<title>Enhancement of Neuron Protection and Neuronal Development Through Exosomes</title>
<p>Although the understanding of astrocyte-neuron communication via exosomes remains unclear, evidence supports that it does occur, and this communication manner is required for neuronal cell survival (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="bibr" rid="B130">Pascua-Maestro et al., 2019</xref>; <xref ref-type="bibr" rid="B111">Luarte et al., 2020</xref>). Neuroprotective signaling is essential for neuronal growth and survival. PrP is a physiologically important receptor protein that protects against oxidative stress in the CNS. Protection of neurons through astrocyte-derived exosomes is dependent on astrocyte-derived exosomal PrP transport into neurons (<xref ref-type="bibr" rid="B66">Guitart et al., 2016</xref>). In addition, studies have demonstrated that microglia and oligodendrocyte-derived exosomes contribute to neuronal energy metabolism by transferring several enzymes involved in energy metabolism (<xref ref-type="bibr" rid="B97">Kramer-Albers et al., 2007</xref>; <xref ref-type="bibr" rid="B44">Drago et al., 2017</xref>). Thus, exosomes mediate several vital processes involved in normal brain function. Taken together, these findings suggest that exosome-mediated cell communication is emerging as a method of mediating neuron protection.</p>
</sec>
</sec>
<sec id="S3">
<title>Pathological Roles of BDEs in AD</title>
<p>Increased secretion of exosomes is generally thought to occur in response to stress or pathological conditions (<xref ref-type="bibr" rid="B169">Urbanelli et al., 2013</xref>; <xref ref-type="bibr" rid="B151">Saxton and Sabatini, 2017</xref>; <xref ref-type="bibr" rid="B56">Gill et al., 2018</xref>), such as hypoxia (<xref ref-type="bibr" rid="B93">King et al., 2012</xref>; <xref ref-type="bibr" rid="B126">Ophelders et al., 2016</xref>), alcoholism (<xref ref-type="bibr" rid="B120">Momen-Heravi et al., 2015</xref>), cisplatin- (<xref ref-type="bibr" rid="B189">Xiao et al., 2014</xref>), or irradiation-induced DNA damage (<xref ref-type="bibr" rid="B106">Lehmann et al., 2008</xref>), and oxidative stress (<xref ref-type="bibr" rid="B10">Atienzar-Aroca et al., 2016</xref>). Neuron-derived exosomes including particular proteins associated with neurodegenerative diseases can be secreted from the affected neurons (<xref ref-type="bibr" rid="B179">Watson et al., 2019</xref>). In the case of AD, there are two hallmarks of AD brains, Aβ and hyperphosphorylated tau, interact with specific endosomes and may contribute to exosome biogenesis in AD (<xref ref-type="bibr" rid="B148">Sardar et al., 2018</xref>). Additionally, exosomal proteins, such as flotillin-1 and Alix, were observed to accumulate around amyloid plaques in AD patients (<xref ref-type="bibr" rid="B140">Rajendran et al., 2006</xref>). The formation, secretion or uptake of exosomes plays a dual role in the spread of oligomers and neurotoxicity (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<sec id="S3.SS1">
<title>Exosomes Containing Aβ in AD</title>
<p>Amyloid β-protein is a C-terminal cleavage product of the transmembrane APP produced by β- and γ-secretase (<xref ref-type="bibr" rid="B40">Devi and Anandatheerthavarada, 2010</xref>; <xref ref-type="bibr" rid="B119">Miranda et al., 2018</xref>). AD is characterized by the presence of aggregates of pathologically misfolded proteins in the brain, including extracellular senile plaques mainly consisting of Aβ (<xref ref-type="bibr" rid="B16">Brunkhorst et al., 2014</xref>). Numerous reports have described these proteins and their substrates within exosomes of <italic>in vitro</italic> AD models and in exosomes derived from neurons of AD patients (<xref ref-type="bibr" rid="B42">Dinkins et al., 2014</xref>; <xref ref-type="bibr" rid="B201">Yuyama et al., 2015</xref>).</p>
<p>Although most AD cases are sporadic, there is a minority patients from mutations in the genes encoding APP or during sequential cleavages by β- and γ-secretase enzyme activities (<xref ref-type="bibr" rid="B27">Chow et al., 2010</xref>). <italic>In vitro</italic>, exosomes isolated from neuronal cell lines show that inducing AD mutations can increase sAPP protein β, sAPPα (<xref ref-type="bibr" rid="B188">Xiao et al., 2017</xref>; <xref ref-type="bibr" rid="B157">Sinha et al., 2018</xref>) and soluble Aβ1-42 (<xref ref-type="bibr" rid="B46">Eitan et al., 2016a</xref>). N2a cells expressing human APP with the autosomal dominant Swedish mutation contain Aβ peptides as well as the C-terminal fragments of APP have also shown increase of production of C-end terminal fragments (a byproduct of APP after β-secretase processing) (<xref ref-type="bibr" rid="B102">Laulagnier et al., 2018</xref>), β-secretase in released exosomes, and co-localization of β-secretase enzyme 1 with early exosome markers (<xref ref-type="bibr" rid="B188">Xiao et al., 2017</xref>). Vesicles released by Aβ-treated astrocytes contain the pro-apoptotic prostate apoptosis response 4 (PAR-4) protein and these vesicles cause PAR-4 associated apoptosis in naive cultures (<xref ref-type="bibr" rid="B177">Wang et al., 2012</xref>). Experiments involving the medium of neural cells expressing familial AD presenilin 1 mutations show that Aβ is associated with exosomes during their excretion process (<xref ref-type="bibr" rid="B47">Eitan et al., 2016b</xref>).</p>
<p><italic>In vivo</italic>, rodent exosomes can contain Aβ, BACE1, and presenilin 1 and 2 (<xref ref-type="bibr" rid="B155">Sharples et al., 2008</xref>). Exosomes isolated from bodily fluids of AD mouse model, including blood, CSF and urine, display indicative increase in the C-terminal fragments of APP (<xref ref-type="bibr" rid="B102">Laulagnier et al., 2018</xref>; <xref ref-type="bibr" rid="B119">Miranda et al., 2018</xref>). Exosomes isolated from bodily fluids of AD patients exhibit a remarkable increase soluble Aβ1–42 in <xref ref-type="bibr" rid="B2">Abner et al. (2016)</xref>; <xref ref-type="bibr" rid="B186">Winston et al. (2016)</xref>, <xref ref-type="bibr" rid="B68">Hamlett et al. (2017</xref>, <xref ref-type="bibr" rid="B69">2018)</xref>. Amyloid plaques in AD brains also contain an exosome marker (<xref ref-type="bibr" rid="B2">Abner et al., 2016</xref>; <xref ref-type="bibr" rid="B186">Winston et al., 2016</xref>; <xref ref-type="bibr" rid="B68">Hamlett et al., 2017</xref>, <xref ref-type="bibr" rid="B69">2018</xref>). The muskelin protein is involved in reorganization of the cytoskeleton and has been shown to be involved in the determination of either lysosomal degradation or exosome secretion of PrP (<xref ref-type="bibr" rid="B74">Heisler et al., 2018</xref>). Importantly, PrP is a receptor for Aβ and is reported to increase the pathogenicity of AD (<xref ref-type="bibr" rid="B30">Cohen et al., 2016</xref>). Muskelin may play a critical role in this type of amyloidosis.</p>
<p>The above data suggested the hypothesis that exosomes could seed Aβ aggregation (<xref ref-type="bibr" rid="B43">Dinkins et al., 2017</xref>). However, neuronal exosomes can also restrain Aβ oligomerization and accelerate Aβ fibril formation, facilitating microglia-mediated Aβ clearance <italic>in vitro</italic> (<xref ref-type="bibr" rid="B199">Yuyama et al., 2012</xref>). Moreover, in an AD mouse model, intracerebral loading of glycosphingolipid-enriched exosomes led to trapping and transporting Aβ into microglia, leading to a decrease in Aβ pathology (<xref ref-type="bibr" rid="B200">Yuyama et al., 2014</xref>). These results might explain why, at least under some circumstances, exosomes associated with Aβ have a physiological, neuroprotective function (<xref ref-type="bibr" rid="B198">Yuyama and Igarashi, 2017</xref>). It is also possible that in the brain as exosomes are secreted by various cell types (e.g., neurons, microglia, and astrocytes), they might exhibit contrary effects or the exosomal membranes might promote Aβ aggregation independent of protein-associated exosomal functions (e.g., Aβ degradation by exosomal insulin-degrading neprilysin or enzymes) (reviewed in <xref ref-type="bibr" rid="B43">Dinkins et al., 2017</xref>).</p>
</sec>
<sec id="S3.SS2">
<title>Exosomes Containing Hyperphosphorylated Tau in AD</title>
<p>The gradual deposition of hyperphosphorylated tau protein within specific neurons is pivotal to the tauopathy of AD (<xref ref-type="bibr" rid="B145">Saman et al., 2014</xref>; <xref ref-type="bibr" rid="B163">Takeda, 2019</xref>). Under normal physiological conditions, incorporation of neuronal microtubule-associated protein tau for microtubule elongation is a crucial event of neuronal synapse formation and synaptic plasticity. Additionally, intracellular tau also participates in neurite outgrowth, axonal transport, chromosome stability, regulation the cellular transcriptome and the structural architecture of heterochromatin (for more details see the review by <xref ref-type="bibr" rid="B160">Sotiropoulos et al., 2017</xref>). Extracellular tau is also secreted into brain interstitial fluid (<xref ref-type="bibr" rid="B193">Yamada et al., 2011</xref>) and may contribute to some characteristics of sleep (<xref ref-type="bibr" rid="B112">Lucey et al., 2019</xref>). The above functions rely on the site-specific phosphorylation of tau (<xref ref-type="bibr" rid="B85">Kapitein and Hoogenraad, 2015</xref>) in normal condition. However, hyperphosphorylation and aggregation of the microtubule-associated tau protein into intracellular neurofibrillary tangles is one of the classical pathological hallmarks of advanced-stage AD (<xref ref-type="bibr" rid="B80">Johnson and Stoothoff, 2004</xref>; <xref ref-type="bibr" rid="B115">Martin et al., 2011</xref>).</p>
<p>During the progressive accumulation of neurofibrillary tangles, tau becomes hyperphosphorylated in neurons. Meanwhile, the cellular clearance machinery takes up tau for degradation and packaging in exosomes (<xref ref-type="bibr" rid="B144">Saman et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Chesser et al., 2013</xref>; <xref ref-type="bibr" rid="B133">Perez et al., 2019</xref>). In an adeno-associated virus-based mouse model revealing rapid tau propagation, microglia help to spread tau through exosome release, and depletion of microglia or inhibition of exosome synthesis significantly decreases the propagation of tau <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B9">Asai et al., 2015</xref>). In another mouse model of tauopathy, aggregated tau was isolated from and transmitted through brain exosomes (<xref ref-type="bibr" rid="B9">Asai et al., 2015</xref>). In these mice, exosomes that were isolated from the brains of tau transgenic rTg4510 mice containing human four-repeat tau with the P301L mutation accelerated pathological tau phosphorylation and oligomer formation (<xref ref-type="bibr" rid="B135">Polanco et al., 2016</xref>), indicating that neuronal exosomes containing human mutated tau are toxic to the recipient neurons <italic>in vivo</italic> (<xref ref-type="bibr" rid="B12">Baker et al., 2016</xref>). Recently, <italic>BIN1</italic> was found to support spreading of tau via exosome release in mice. Tau-containing exosomes isolated from the CSF of AD-affected individuals who contain <italic>BIN1</italic>-associated genetic variants in AD etiology showed seeding competence (<xref ref-type="bibr" rid="B33">Crotti et al., 2019</xref>). In human patients, compared with BDEs obtained from the plasma or serum of age-matched controls, BDEs from AD patients showed a 3-20-fold increase in tau phosphorylation at threonine 181 (p-T181-tau) and serine 396 (p-S396-tau) (<xref ref-type="bibr" rid="B33">Crotti et al., 2019</xref>). Moreover, compared with AD patients who had only been diagnosed with mild cognitive impairment, p-T181-tau levels were significantly higher in BDEs isolated from the plasma of later-stage AD patients (<xref ref-type="bibr" rid="B186">Winston et al., 2016</xref>), demonstrating either a dysfunction of the clearance ability or an increase in pathogenicity of exosomes in later disease states of AD. p-T181- and p-S396-tau were significantly decreased in BDEs of patients 1–10 years prior to their AD diagnosis (<xref ref-type="bibr" rid="B51">Fiandaca et al., 2015</xref>).</p>
</sec>
<sec id="S3.SS3">
<title>Exosomes Containing Synaptic Proteins in AD</title>
<p>One consequence of AD is neuron loss and dysfunction. The levels of synaptic proteins, including synaptophysin, synaptotagmins, synaptobrevin, synaptopodin, Rab3A, GAP 43, and neurogranin, were decreased in the BDE cargo from the plasma of AD patients (<xref ref-type="bibr" rid="B63">Goetzl et al., 2016b</xref>). Additionally, low-density LRP 6, REST, heat shock factor protein 1, HSP, and AMPA receptor levels are also lower in BDEs from the plasma of AD patients (<xref ref-type="bibr" rid="B61">Goetzl et al., 2015</xref>, <xref ref-type="bibr" rid="B63">2016b</xref>; <xref ref-type="bibr" rid="B186">Winston et al., 2016</xref>). Furthermore, neurexin 2α, GluA4-containing glutamate receptor, and neuroligin 1, essential proteins for long-term potentiation processes, were all significantly reduced in BDEs from the plasma of patients 6−11 years prior to AD diagnosis and, along with neuronal pentraxin 2, were all downregulated in BDEs (<xref ref-type="bibr" rid="B60">Goetzl et al., 2018</xref>, <xref ref-type="bibr" rid="B64">2019</xref>). These proteins are all involved in normal homeostasis of neurons. Further research into these proteins in BDEs could be beneficial for the search for earlier biomarkers of AD.</p>
</sec>
<sec id="S3.SS4">
<title>Ceramide and Sphingosine-1-Phosphate (S1P) in Exosomes in AD</title>
<p>Activated sphingolipids are signaling molecules that serve as intracellular second messengers and include ceramide, sphingosine, and their derivatives, 1-phosphates (C1P and S1P, respectively) (<xref ref-type="bibr" rid="B35">Czubowicz et al., 2019</xref>). Exosomes are sphingomyelin- and ceramide-enriched vesicles formed inside MVEs and then are secreted when the MVE membrane fuses with the plasmalemma. Exosomes can serve as a vehicle for the extracellular secretion and cell-to-cell transport of Aβ, α-synuclein and tau protein, possibly further facilitating the spread of toxic protein aggregation (<xref ref-type="bibr" rid="B125">Ngolab et al., 2017</xref>; <xref ref-type="bibr" rid="B178">Wang et al., 2017</xref>). S1P receptor (S1PR) signaling has been reported to participate in exosomal cargo sorting. Activity of the S1PR-mediated Rho family of GTPases is essential for this process and Gβγ inhibitors inhibit this activity (<xref ref-type="bibr" rid="B83">Kajimoto et al., 2018</xref>). The secretion of exosomes can be regulated by the activation of neutral sphingomyelin synthase 2 (SMS2) and sphingomyelinase 2 (nSMase2), demonstrating distinct functions for these enzymes in AD (<xref ref-type="bibr" rid="B199">Yuyama et al., 2012</xref>; <xref ref-type="bibr" rid="B42">Dinkins et al., 2014</xref>). Additionally, ceramide/sphingolipid shortage results in enhanced secretion of sAβPPα, the product of non-amyloidogenic cleavage. However, this shortage gives rise to increased secretion of Aβ42 at the same time, probably via regulation of raft-associated proteins, resulting in alteration of the α- <italic>vs.</italic>β-cleavage ratio (<xref ref-type="bibr" rid="B199">Yuyama et al., 2012</xref>; <xref ref-type="bibr" rid="B42">Dinkins et al., 2014</xref>). Enhanced endogenous ceramide and exogenous additional ceramide both elevate the Aβ level (<xref ref-type="bibr" rid="B137">Puglielli et al., 2003</xref>; <xref ref-type="bibr" rid="B150">Sawamura et al., 2004</xref>). The above research suggests the significance of the ceramide/sphingolipid levels in the process of AD.</p>
</sec>
<sec id="S3.SS5">
<title>Exosomes Containing Other AD-Associated Proteins</title>
<p>Dysregulation of insulin by the CNS and peripheral hyperinsulinemia have been reported as other events highly associated with AD (<xref ref-type="bibr" rid="B36">de la Monte, 2009</xref>; <xref ref-type="bibr" rid="B37">de la Monte and Tong, 2014</xref>; <xref ref-type="bibr" rid="B91">Kim et al., 2015</xref>). A low tyrosine phosphorylated insulin receptor substrate 1 (IRS1) to serine phosphorylated IRS1 ratio is a characteristic of insulin dysregulation (<xref ref-type="bibr" rid="B3">Aguirre et al., 2002</xref>; <xref ref-type="bibr" rid="B45">Draznin, 2006</xref>) and is related to greater brain atrophy in AD patients (<xref ref-type="bibr" rid="B124">Mullins et al., 2017</xref>). BDEs isolated from the plasma of human AD patients have revealed an enhancement in serine phosphorylation in IRS1 (<xref ref-type="bibr" rid="B86">Kapogiannis et al., 2015</xref>). This study demonstrated that significant differences in the IRS1 levels were recognizable up to 10 years prior to clinical onset of AD, which suggests that proteins within BDEs that are involved in insulin disruption may potentially be useful biomarkers for clinical diagnosis.</p>
<p>Moreover, exosomes have the ability to spread toxic proteins through PrP activity (<xref ref-type="bibr" rid="B71">Hartmann et al., 2017</xref>). PrP is a cell surface-anchored protein that is highly related to AD pathology (<xref ref-type="bibr" rid="B89">Kellett and Hooper, 2009</xref>). Its pathological, misfolded form is associated with spongiform encephalopathy (<xref ref-type="bibr" rid="B136">Prusiner, 1982</xref>; <xref ref-type="bibr" rid="B159">Song et al., 2013</xref>). Studies in animal models of AD have demonstrated that the PrP receptor is essential for the cognitive impairment linked to Aβ (<xref ref-type="bibr" rid="B57">Gimbel et al., 2010</xref>). Additionally, growing evidence indicates that prion receptor on exosomes are capable of transmitting pathological substances (<xref ref-type="bibr" rid="B50">Fevrier et al., 2004</xref>; <xref ref-type="bibr" rid="B71">Hartmann et al., 2017</xref>). Aberrant autophagy is likely to play a role in this process (<xref ref-type="bibr" rid="B1">Abdulrahman et al., 2018</xref>). However, further research is needed to explore the potential mechanism connecting exosomes, AD pathogenesis, and autophagy.</p>
</sec>
</sec>
<sec id="S4">
<title>Exosomal MiRNA as a Diagnostic Biomarker for AD</title>
<p>Generally, the biomarkers used for AD diagnosis include the expression of Aβ and pTau (<xref ref-type="bibr" rid="B1">Abdulrahman et al., 2018</xref>), and methods such as neuropsychological testing and specialized brain imaging techniques have also been widely used for diagnosis of AD. Unfortunately, most AD patients are asymptomatic during the pre-clinical stages, which may last up to 17 years or longer (<xref ref-type="bibr" rid="B176">Villemagne et al., 2013</xref>). Therefore, it is important to exploit early diagnostics to confirm and treat individuals who are at risk before severe and irreversible neuronal pathology occurs.</p>
<p>MiRNAs are a family of 18–22 nt single-stranded RNAs that post-translationally communicate with and regulate the expression of mature mRNAs. Single upregulated miRNAs can target various mRNAs to decrease their expression and multiple miRNAs can target a single mRNA (<xref ref-type="bibr" rid="B153">Sethi and Lukiw, 2009</xref>; <xref ref-type="bibr" rid="B149">Sarkar et al., 2016</xref>). Studies have demonstrated that mRNA and miRNA species are present in exosomes. It is possible that some mRNA sequences are definitely targeted for secretion by these vesicles (<xref ref-type="bibr" rid="B170">Valadi et al., 2007</xref>; <xref ref-type="bibr" rid="B172">Van Giau and An, 2016</xref>). Exosomal miRNAs play essential roles in intercellular communication between cell membranes in the CNS and in disease progression. Exosomal miRNAs are also ideal targets for use as potential biomarkers in clinical diagnostics or therapies as they can be analyzed through neuronal exosomes in the patient’s body fluids (A). Indeed, some research has illustrated that proteins and miRNAs can be transferred from glia to axons (<xref ref-type="bibr" rid="B158">Skog et al., 2008</xref>). It is assumed that miRNA signaling can impact neurodegenerative diseases via the dysregulation of tau, leading to neurotoxicity. One study convincingly demonstrated that, in brain tissues obtained at autopsy from AD patients and from those with severe primary age-related tau pathology, the level of the highly conserved miRNA-219 was decreased in the brain (<xref ref-type="bibr" rid="B147">Santa-Maria et al., 2015</xref>). Several reports have illustrated that high expression of tissue-specific miRNAs in the brain, such as miR-9, miR-29a/b, miR-107, miR-124, miR-128, miR-134, and miR-137, may result in defective neuronal development (<xref ref-type="bibr" rid="B152">Sempere et al., 2004</xref>; <xref ref-type="bibr" rid="B88">Kawase Koga et al., 2009</xref>; <xref ref-type="bibr" rid="B76">Huang et al., 2010</xref>). In addition, other miRNAs are also abnormal in brain tissues during neurodegenerative processes. These specific miRNAs, including miR-132 and miR-212, are among the most robustly declining miRNAs in neurodegenerative diseases, including AD (<xref ref-type="bibr" rid="B29">Cogswell et al., 2008</xref>; <xref ref-type="bibr" rid="B72">Hebert et al., 2013</xref>; <xref ref-type="bibr" rid="B187">Wong et al., 2013</xref>; <xref ref-type="bibr" rid="B101">Lau et al., 2014</xref>), Huntington’s disease (<xref ref-type="bibr" rid="B81">Johnson et al., 2008</xref>; <xref ref-type="bibr" rid="B128">Packer et al., 2008</xref>), PD (<xref ref-type="bibr" rid="B19">Burgos et al., 2014</xref>), schizophrenia and bipolar disorders (<xref ref-type="bibr" rid="B134">Perkins et al., 2007</xref>; <xref ref-type="bibr" rid="B90">Kim et al., 2010</xref>) and frontotemporal dementia (<xref ref-type="bibr" rid="B23">Chen-Plotkin et al., 2012</xref>; <xref ref-type="bibr" rid="B72">Hebert et al., 2013</xref>).</p>
<p>Remarkably, miRNAs that were found to be greatly expressed in the brain were also detected in human body fluids such as the plasma, urine, and CSF. The levels of brain-enriched miRNAs including miR-9, miR-29a, miR-29b, and miR-137 have been found to be significantly decreased in plasma samples collected from AD patients (<xref ref-type="bibr" rid="B55">Geekiyanage et al., 2012</xref>). Both miR-128 and miR-134 were also examined in patients with mild cognitive impairment, which is an early stage of AD (<xref ref-type="bibr" rid="B156">Sheinerman et al., 2012</xref>). These miRNA biomarkers in the blood represents a clinical advantage for early disease diagnosis, but differential miRNA expression may not accurately rescue abnormal miRNA expression in the brain. The CSF represents a more relevant and suitable source for the diagnosis of CNS disorders such as AD (<xref ref-type="bibr" rid="B4">Alexandrov et al., 2012</xref>; <xref ref-type="bibr" rid="B131">Patz et al., 2013</xref>; <xref ref-type="bibr" rid="B172">Van Giau and An, 2016</xref>) because CSF is a clear biological fluid produced in the choroid plexus of the brain that circulates via the inner ventricular system, crosses the BBB, and is absorbed into the bloodstream. The levels of target candidate miRNAs such as miR-9, miR-146a, and miR-155 were shown to be greatly increased in CSF from AD patients compared with those in age-matched controls, as quantified by microarrays and qRT-PCR (<xref ref-type="bibr" rid="B4">Alexandrov et al., 2012</xref>; <xref ref-type="bibr" rid="B113">Lukiw et al., 2012</xref>). Currently, urine is collected and analyzed for biomarker discovery and diagnostic purposes in clinical practice (<xref ref-type="bibr" rid="B183">Weber et al., 2010</xref>; <xref ref-type="bibr" rid="B17">Bryant et al., 2012</xref>). Exosomes can be purified from the urine using various methods such as differential ultracentrifugation (<xref ref-type="bibr" rid="B6">Alvarez et al., 2012</xref>), which is highly valuable for investigating whether miRNAs can be detected in the urine. However, it remains difficult to determine whether the alteration in miRNA levels in humans is a cause or consequence of the neurodegenerative process. Investigation of miRNA analysis profiles in AD animal models might help to solve this problem. Additionally, the potential to test miRNAs in biological body fluids may contribute to developing and promoting the discovery of specific biomarkers for neurodegenerative diseases such as AD.</p>
</sec>
<sec id="S5">
<title>Development of a Brain-Derived Exosomal Biomarker for AD</title>
<p>Currently, a mixed population of exosomes from various types of cells can be separated from biological fluids by multiple techniques such as classically differential ultracentrifugation, immunomagnetic beads and size exclusion chromatography (<xref ref-type="bibr" rid="B107">Li et al., 2017</xref>; <xref ref-type="bibr" rid="B197">Yu et al., 2018</xref>). Moreover, exosomes have a lipid bilayer to protect their cargo, which is used downstream, from RNAse treatment to be confirmed whether the miRNAs/mRNA analyzed are inside the exosomes or not (<xref ref-type="bibr" rid="B22">Cheng et al., 2014</xref>). This mixed population of exosomes may be recognized by western blots or mass spectrometry using proteins that are involved in the formation process of ILVs (<xref ref-type="bibr" rid="B110">Lotvall et al., 2014</xref>) as mentioned and discussed at the beginning of this manuscript. It is worth noting that many of these markers are not exclusive to exosomes and it is necessary to further examine the characteristics of exosomes (<xref ref-type="bibr" rid="B180">Watt et al., 2011</xref>). In the CNS, investigating cells from the brain may afford insights into the mechanisms of brain diseases (<xref ref-type="bibr" rid="B143">Saeedi et al., 2019</xref>). Isolating neuronal exosomes from cells related to AD may bridge the gaps in knowledge of peripheral biomarkers and provide mechanistic insight to this disease. Recently, a precipitation/immunoaffinity system has been developed to isolate neuron-derived and astrocyte-derived exosomes from the blood of AD patients (<xref ref-type="bibr" rid="B60">Goetzl et al., 2018</xref>). Data from these studies suggest that BDEs from blood plasma and measurement of certain forms of tau in BDEs can be used as diagnostic and prognostic biomarkers for AD (<xref ref-type="bibr" rid="B67">Guix et al., 2018</xref>; <xref ref-type="bibr" rid="B143">Saeedi et al., 2019</xref>).</p>
<p>Enrichment of a specific neuron-derived population of exosomes permits monitoring of target cells of interest (<xref ref-type="table" rid="T2">Table 2</xref>). Collectively, although exosome transfer of Aβ seems to mainly occur in AD and can be exploited as a helpful biomarker of the disease course, development of additional exosome biomarkers could contribute to a more accurate diagnosis of AD and discovering further close connections between the marker and mechanisms of the early stage of AD as well as other neurodegenerative diseases.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>The biomarker of different neural derived exosomes (NDEs).</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Exosomes isolated from different cell types</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Biomarker</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Function</bold>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cortical neurons-derived exosomes; immature and mature hippocampal neurons exosomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">The GluR2/3 subunits of glutamate receptors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuronal markers and play key roles in virtually all excitatory neurotransmission in the brain <xref ref-type="bibr" rid="B49">Faure et al., 2006</xref>.</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">L1 cell adhesion molecule (L1CAM)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuronal markers, cell adhesion molecule with an important role in the development of the nervous system <xref ref-type="bibr" rid="B99">Lachenal et al., 2011</xref>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Microglia-derived exosomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ionized calcium binding adaptor molecule 1 (Iba1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">A microglia/macrophage-specific calcium-binding protein with actin-bundling activity that participates in membrane ruffling and phagocytosis in activated microglia <xref ref-type="bibr" rid="B138">Raffo-Romero et al., 2018</xref>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytic-derived exosomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamine aspartate transporter (GLAST)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Selective markers of astrocytic plasma membranes <xref ref-type="bibr" rid="B138">Raffo-Romero et al., 2018</xref>.</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Glial fibrillary acidic protein (GFAP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">A specific marker for astrocytes; the astrocytic cytoskeleton <xref ref-type="bibr" rid="B63">Goetzl et al., 2016b</xref>.</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamine synthetase (GS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocyte marker, it catalyzes the production of glutamine and 4-aminobutanoate <xref ref-type="bibr" rid="B63">Goetzl et al., 2016b</xref>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Oligodendrocytes-derived exosomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Myelin proteolipid protein (PLP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oligodendrocytes marker, it is the major myelin protein from the central nervous system. It plays an important role in the formation or maintenance of the multilamellar structure of myelin <xref ref-type="bibr" rid="B97">Kramer-Albers et al., 2007</xref>.</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oligodendrocytes marker, it belongs to the cyclic nucleotide phosphodiesterase family <xref ref-type="bibr" rid="B97">Kramer-Albers et al., 2007</xref>.</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="S6">
<title>Exosomes as Novel AD Therapeutics</title>
<p>The BBB is a continuous endothelial membrane within brain microvessels and is sheathed by mural vascular cells and perivascular astrocyte end-feet, which seal the cell−to−cell contacts to prevent the transmission of potentially toxic compounds between the brain and the blood (<xref ref-type="bibr" rid="B116">Matsumoto et al., 2017</xref>). In addition to transmembrane diffusion of small (&lt;400 Da) lipid-soluble molecules, the BBB permits selective transport of some compounds into and out of the brain (<xref ref-type="bibr" rid="B146">Sanchez-Covarrubias et al., 2014</xref>).</p>
<p>Exosomes have an inherent ability to cross the BBB, and because their properties remain active in the brain, they are ideal drug delivery vehicles. This BBB-penetrating capacity, which was first reported by <xref ref-type="bibr" rid="B7">Alvarez-Erviti et al. (2011)</xref>, resulted in effective delivery of small-molecule drugs to the brain through systemic injection of naked exosomes in mice, leading to promotion of drug-mediated biological responses (<xref ref-type="bibr" rid="B205">Zhuang et al., 2011</xref>). Later studies have been successful in transmitting exosomes through intranasal injection into the mouse brain (<xref ref-type="bibr" rid="B5">Aliotta et al., 2007</xref>). Recently, a study using rats identified that the fluorescently tagged forebrain astrocyte protein aldolase C was selectively expressed in brain tissue and could be recovered in exosomes in the blood (<xref ref-type="bibr" rid="B142">Ratajczak et al., 2006</xref>; <xref ref-type="bibr" rid="B65">Gomez-Molina et al., 2019</xref>). This study affords evidence of communication mediated by exosomes from the brain to the rest of the body (<xref ref-type="bibr" rid="B142">Ratajczak et al., 2006</xref>; <xref ref-type="bibr" rid="B65">Gomez-Molina et al., 2019</xref>). Evidence from these studies illustrates that exosomes can cross the BBB in a bi-directional manner; however, their method of accurately crossing the BBB remains unclear and requires further study.</p>
<p>In contrast, while exosomes may play a role in the spreading of AD, some studies have shown a positive effect of introducing non-pathogenic exosomes to change disease duration and progression (<xref ref-type="table" rid="T3">Table 3</xref>). In animal studies, this therapeutic effect was found when exosomes from young mice were observed to significantly downregulate aging-associated signaling molecules such as IGF1R and upregulate telomerase-related genes such as <italic>Men1, Mre11a, Tep1, Terf2, Tert</italic>, and <italic>Tnks</italic> in aged mice (<xref ref-type="bibr" rid="B103">Lee et al., 2018</xref>). Furthermore, exosomes injected into the brain of transgenic mouse models of AD can help to decrease toxic oligomers and fibrils in a microglial-dependent manner following intracerebral administration, contributing to the clearance of Aβ <italic>in vivo</italic> (<xref ref-type="bibr" rid="B199">Yuyama et al., 2012</xref>, <xref ref-type="bibr" rid="B200">2014</xref>; <xref ref-type="bibr" rid="B198">Yuyama and Igarashi, 2017</xref>). Other researchers have suggested that mesenchymal stromal-derived exosomes may have a therapeutic effect <italic>in vivo</italic> on the advancement of neurovascular plasticity in other neurodegenerative diseases such as stroke (<xref ref-type="bibr" rid="B191">Xin et al., 2013a</xref>).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Exosome administration for the treatment of AD and other neurological disorders.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Disease</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Animal model</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Source</bold>
</td>
<td align="center" colspan="4" rowspan="1" valign="top">
<bold>Administration</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Proposed mechanism and results</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Concentration (Total amount)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Route</td>
<td align="left" colspan="1" rowspan="1" valign="top">Period (time)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sampling/Sacrifice</td>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">APP<sup>sweInd</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">N2a cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 mg / mL, 0.25 μL/h (168 μg)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dentate gyrus</td>
<td align="left" colspan="1" rowspan="1" valign="top">14 days (continuously)</td>
<td align="left" colspan="1" rowspan="1" valign="top">14 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aβ clearence. Aβ level ↓; Amyloid deposit ↓; Synaptotoxicity ↓</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B200">Yuyama et al., 2014</xref>, <xref ref-type="bibr" rid="B201">2015</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">APP<sup>sweInd</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Plateletfreeplasma</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 μg / 3 μL (3 μg)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dentate gyrus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Single injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 days / 20 days after injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Co-localization (exosome and Aβ)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B203">Zheng et al., 2017</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">hiPSCs Injected mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tau mutation hiPSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.5 μg / 2 μL (0.5 μg)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Single injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 m / 2 m after injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tau propagation. Neurodegeneration ↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B185">Winston et al., 2019</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">5XFAD pups</td>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocyte</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Single injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">48 h after injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aβ plaque ↓ by exosome ↓. nSMase2 ↓; exosome ↓; Aβ plaque ↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B42">Dinkins et al., 2014</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Aβ-derived diffusible ligands injected mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">N2a cells human CSF</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 μg / 5 μL 4 μg</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.C.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Single injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic plasticity. LTP↑, Aβ action ↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B8">An et al., 2013</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">AD mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">hUmbilical cord MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">30 μg / 0.1 mL 120 μg</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 month (biweekly injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 m after injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuron inflammation↓. Aβ deposit ↓; activation of microglia ↓; pro-inflammatory levels ↑; anti-inflamatory cytokines ↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B41">Ding et al., 2018</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">APP<sup>sweInd</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">(hypoxia) PC-MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">150 μg / 80 μL 1200 μg</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 month (biweekly injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">5 h after injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroprotection and Immunomodulation. Plaque deposition ↓; Aβ level ↓; activation of astrocytes ↓; activation of microglia ↓; TNF-α, IL-1β↓; IL-4 ↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B34">Cui et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stroke</td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAo, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 × 10<sup>6</sup> / mL 3 × 10<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">24 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">14 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">White matter repair</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B34">Cui et al., 2018</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAo, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">100 μg / 0.5 ml 100 μg</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">24 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">28 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">White matter repair</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B191">Xin et al., 2013a</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAo, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">100 μg/0.5 mL 100 μ<underline>g</underline></td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">24 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">28 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">White matter repair</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B190">Xin et al., 2017</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Embolism, mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">NSC EV</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 / 14 / 38 h after surgery (triple injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">96 h after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Immune modulation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B182">Webb et al., 2018b</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">MCAo, pig</td>
<td align="left" colspan="1" rowspan="1" valign="top">NSC EV</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 / 14 / 24 h after surgery (triple injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 / 84 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduction in edema</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B181">Webb et al., 2018a</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ICH, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 / 7 / 28 days after injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Immunosuppression</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B127">Otero-Ortega et al., 2018</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">White matter remodeling</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B18">Buller et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TBI</td>
<td align="left" colspan="1" rowspan="1" valign="top">CCI, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">hMSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">100 μg / 0.5 ml 100 μg</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">35 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Angiogenesis and neurogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B202">Zhang et al., 2017</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ICH, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 × 10<sup>6</sup> MSCs 3 × 10<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Angiogenesis and neurogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B92">Kim et al., 2016</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">TBI, swine</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 × 10<sup>15</sup>; 1 × 10<sup>13</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">6 h / 1 / 5 / 9 / 13 days</td>
<td align="left" colspan="1" rowspan="1" valign="top">30 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroprotection</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B184">Williams et al., 2019</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fetal hypoxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCD singleton fetuses</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.0 × 10<sup>7</sup> cell; 4.0 × 10<sup>7</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 h / 4 days (2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">7 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroprotection</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B184">Williams et al., 2019</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ICH</td>
<td align="left" colspan="1" rowspan="1" valign="top">ICH, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">100 μg protein I.V., 200 μg</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">24 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">28 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurovascular and white matter remodeling.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B70">Han et al., 2018</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ICH, rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">100 μg protein I.V., 100 μg</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">24 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">28 days after surgery</td>
<td align="left" colspan="1" rowspan="1" valign="top">White matter repair</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B127">Otero-Ortega et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Focal ischemia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Photo thrombosis, mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">BM-MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.V.</td>
<td align="left" colspan="1" rowspan="1" valign="top">24 h after surgery (single injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 h after injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B194">Yang et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">BTBR T+tf/J mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">hMSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.81 × 10<sup>8</sup> particles/5 μL 1.9 ×10<sup>9</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">I.N.</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 days (every other day injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Behavior test</td>
<td align="left" colspan="1" rowspan="1" valign="top">Social interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B132">Perets et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Inflammation</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6j mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">EL-4 T cell</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 μg / 2 μL 10 μg / 10 μL</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.N.</td>
<td align="left" colspan="1" rowspan="1" valign="top">10 min (every 2 min injection)</td>
<td align="left" colspan="1" rowspan="1" valign="top">After administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Anti-inflammation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B205">Zhuang et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Status epileoticus</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">MSCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">∼ 5 μg 30 μg / 150 μL</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.N.</td>
<td align="left" colspan="1" rowspan="1" valign="top">18 h (every 5 min)</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 days after administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurogenesis and memory dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B109">Long et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bacterial infection</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">BMDCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">25 μg / 30 μL 75 μg / 90 μL</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.N.</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 week (three doses)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 week after immunization</td>
<td align="left" colspan="1" rowspan="1" valign="top">Macrophage and dendritic cell activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B58">Giri et al., 2010</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bone marrow cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">25 μg / 30 μL 75 μg / 90 μL</td>
<td align="left" colspan="1" rowspan="1" valign="top">I.N.</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 week (three doses)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 week after dose</td>
<td align="left" colspan="1" rowspan="1" valign="top">Potential mechanism for antigen cross-priming</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B59">Giri and Schorey, 2008</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>APP<sup><italic>swelnd</italic></sup>, mice expressing the human APP bearing the Swedish and Indiana (KM670/671NL, V717F) mutations (J20); ASD, autism spectrum disorders; BM-MSCs, bone marrow mesenchymal stem cells; CCI, controlled cortical impact; CSF, cerebrospinal fluid; hiPSCs, human induced pluripotent stem cells; EV, extracellular vesicles; ICH, intracerebral hemorrhage; I.C.V., intracerebroventricularly infusion; IL, interleukin; I.N., intranasal administration; I.V., intravenous injection; LTP, Long-term potentiation; MCAo, middle cerebral artery occlusion; MSCs, mesenchymal stem cells; NA, not applicable; NSC, Neural stem cell; OCD, occluder; PC-MSCs, preconditioned mesenchymal stem cells; TBI, traumatic brain injury; TNF-α.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>Additionally, directed exosomal transmission systems for precision nanomedicine have attracted extensive interest across the fields of pharmaceutical sciences, molecular cell biology and nanoengineering (<xref ref-type="bibr" rid="B204">Zhu et al., 2018</xref>). Exosomes are also a promising type of novel drug delivery vehicle because of their ability to cross the BBB and shield their cargo from enzymatic and chemical degradation. Recent developments regarding nanoengineering using targeted exosomes for therapeutic purposes have been conducted by researchers, for example, <xref ref-type="bibr" rid="B192">Xin et al. (2013b)</xref>, <xref ref-type="bibr" rid="B167">Tran et al. (2019)</xref>.</p>
<p>Introducing exogenous exosomes into the CNS because they can effectively cross the BBB is a potentially novel strategy for AD therapies (<xref ref-type="bibr" rid="B21">Chen et al., 2016</xref>), and their innate secretion of enzymes could be beneficial for degrading toxic fibrils (<xref ref-type="bibr" rid="B87">Katsuda et al., 2015</xref>). The field of EV research is still at the initial stage in the CNS and yet improved therapeutic applications are already being developed.</p>
</sec>
<sec id="S7">
<title>Opportunities and Challenges</title>
<p>Quantifying changes in EV cargo would be extremely difficult because of the lack of unique region-specific markers for circulating exosomes and the inaccessibility of specific brain tissue EVs from living patients. Interesting lines of research have examined both the induction of AD using pathogenic EVs and the sequestration of toxic plaques using exogenous healthy EVs.</p>
<p>It difficult to distinguish among EV types simply on the basis of protein markers or size alone. To better interpret and replicate the experimental results of exosome studies, combined exosome isolation methods as well as improved techniques for accurate purification and characterization are recommended. In addition, a crowdsourcing knowledgebase currently allows researchers in the EV field to track the latest EV biology and methodology (<xref ref-type="bibr" rid="B104">Lee et al., 2019</xref>).</p>
<p>In recent years, research has been focused on BDEs to attempt to solve questions of brain-associated disorders using blood biopsies. Exosomes isolated from plasma were used to enrich BDEs (<xref ref-type="bibr" rid="B162">Sun et al., 2017</xref>; <xref ref-type="bibr" rid="B143">Saeedi et al., 2019</xref>). This study demonstrated that both the number of neural-derived exosomes as well as the expression of Aβ, neurofilament light chain, and high-mobility group box 1 potentially act as biomarkers of neuropsychological impairment in HIV (<xref ref-type="bibr" rid="B162">Sun et al., 2017</xref>). BDEs from plasma have also been tested in a pilot study to examine protein biomarkers for patients with major depressive disorder (<xref ref-type="bibr" rid="B98">Kuwano et al., 2018</xref>). Moreover, in military personal with mild traumatic brain injuries, compared with controls, the levels of tau, Aβ42, and IL-10 deposited by BDEs were elevated (<xref ref-type="bibr" rid="B98">Kuwano et al., 2018</xref>). Cargo proteins and miRNA from astrocytic-derived exosomes have been analyzed to obtain mechanistic insight into AD (<xref ref-type="bibr" rid="B63">Goetzl et al., 2016b</xref>). Additionally, other cell-derived exosomes have also been researched for other brain-related disorders. The ability to access BDEs in plasma and other biological body fluids such as CSF and urine shows potential for clinical use in treating nervous system disorders.</p>
</sec>
<sec id="S8">
<title>Conclusion</title>
<p>Although the domain of exosome investigation, especially BDEs, remains relatively novel, attractive evidence from other fields demonstrates that investigation of exosomes can afford insight into the disease mechanisms and processes associated with AD and treatment responses. Currently, increased research on exosomes has focused on biomarkers of the course of AD and their ability to mediate cell-to-cell communication in the nervous system. However, additional work is needed with respect to the mechanisms of bi-directional transport of cargo-carrying exosomes across the BBB, the alterations in the number or size of exosomes secreted, changes in cargo constituents, and identification of differences in specific cell types. Meantime, it is necessary to take into consideration that several preparations may contain another type of EVs given the procedure used to obtain them. Exosomes derived from cells in the CNS have tremendous biomarker potential because they may reverse physiological changes in nervous system disorders, and these changes can be tested in the periphery.</p>
</sec>
<sec id="S9">
<title>Author Contributions</title>
<p>CQ and ZS designed the project. ZS, YX, WD, LZ, HZ, YH, PY, YQ, and WZ performed a majority of writing the manuscript. All authors reviewed and revised the manuscript.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81901114); the Fundamental Research Funds for the Central Universities (Grant No. 3332019091); and CAMS Innovation Fund for Medical Sciences (Grant Nos. 2019-I2M-1-003 and 2016-12M-2-006); and Young Elite Scientists Sponsorship Program by CAST (YESS) (Grant No. 2019QNRC001).</p>
</fn>
</fn-group>
<ack>
<p>ZS wishes to extend her deepest appreciation and thanks to her husband, Mr. Xing Le, who has always supported her career and research.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulrahman</surname><given-names>B. A.</given-names></name><name><surname>Abdelaziz</surname><given-names>D. H.</given-names></name><name><surname>Schatzl</surname><given-names>H. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Autophagy regulates exosomal release of prions in neuronal cells.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>293</volume>
<fpage>8956</fpage>–<lpage>8968</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA117.000713</pub-id>
<pub-id pub-id-type="pmid">29700113</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abner</surname><given-names>E. L.</given-names></name><name><surname>Jicha</surname><given-names>G. A.</given-names></name><name><surname>Shaw</surname><given-names>L. M.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><name><surname>Goetzl</surname><given-names>E. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Plasma neuronal exosomal levels of Alzheimer’s disease biomarkers in normal aging.</article-title>
<source/><italic>Ann. Clin. Transl. Neurol.</italic>
<volume>3</volume>
<fpage>399</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1002/acn3.309</pub-id>
<pub-id pub-id-type="pmid">27231710</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguirre</surname><given-names>V.</given-names></name><name><surname>Werner</surname><given-names>E. D.</given-names></name><name><surname>Giraud</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>Y. H.</given-names></name><name><surname>Shoelson</surname><given-names>S. E.</given-names></name><name><surname>White</surname><given-names>M. F.</given-names></name></person-group> (<year>2002</year>). <article-title>Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>277</volume>
<fpage>1531</fpage>–<lpage>1537</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M101521200</pub-id>
<pub-id pub-id-type="pmid">11606564</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexandrov</surname><given-names>P. N.</given-names></name><name><surname>Dua</surname><given-names>P.</given-names></name><name><surname>Hill</surname><given-names>J. M.</given-names></name><name><surname>Bhattacharjee</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2012</year>). <article-title>microRNA (miRNA) speciation in Alzheimer’s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).</article-title>
<source/><italic>Int. J. Biochem. Mol. Biol.</italic>
<volume>3</volume>
<fpage>365</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="pmid">23301201</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aliotta</surname><given-names>J. M.</given-names></name><name><surname>Sanchez-Guijo</surname><given-names>F. M.</given-names></name><name><surname>Dooner</surname><given-names>G. J.</given-names></name><name><surname>Johnson</surname><given-names>K. W.</given-names></name><name><surname>Dooner</surname><given-names>M. S.</given-names></name><name><surname>Greer</surname><given-names>K. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation.</article-title>
<source/><italic>Stem Cells</italic>
<volume>25</volume>
<fpage>2245</fpage>–<lpage>2256</lpage>. <pub-id pub-id-type="doi">10.1634/stemcells.2007-0128</pub-id>
<pub-id pub-id-type="pmid">17556595</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>M. L.</given-names></name><name><surname>Khosroheidari</surname><given-names>M.</given-names></name><name><surname>Kanchi</surname><given-names>R. R.</given-names></name><name><surname>DiStefano</surname><given-names>J. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers.</article-title>
<source/><italic>Kidney Int.</italic>
<volume>82</volume>
<fpage>1024</fpage>–<lpage>1032</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2012.256</pub-id>
<pub-id pub-id-type="pmid">22785172</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Erviti</surname><given-names>L.</given-names></name><name><surname>Seow</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>H.</given-names></name><name><surname>Betts</surname><given-names>C.</given-names></name><name><surname>Lakhal</surname><given-names>S.</given-names></name><name><surname>Wood</surname><given-names>M. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.</article-title>
<source/><italic>Nat. Biotechnol.</italic>
<volume>29</volume>
<fpage>341</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1807</pub-id>
<pub-id pub-id-type="pmid">21423189</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>K.</given-names></name><name><surname>Klyubin</surname><given-names>I.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>J. H.</given-names></name><name><surname>Mably</surname><given-names>A. J.</given-names></name><name><surname>O’Dowd</surname><given-names>S. T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo.</article-title>
<source/><italic>Mol:Brain</italic>
<volume>6</volume>
<issue>47</issue>
<pub-id pub-id-type="doi">10.1186/1756-6606-6-47</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asai</surname><given-names>H.</given-names></name><name><surname>Ikezu</surname><given-names>S.</given-names></name><name><surname>Tsunoda</surname><given-names>S.</given-names></name><name><surname>Medalla</surname><given-names>M.</given-names></name><name><surname>Luebke</surname><given-names>J.</given-names></name><name><surname>Haydar</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Depletion of microglia and inhibition of exosome synthesis halt tau propagation.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>18</volume>
<fpage>1584</fpage>–<lpage>1593</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4132</pub-id>
<pub-id pub-id-type="pmid">26436904</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atienzar-Aroca</surname><given-names>S.</given-names></name><name><surname>Flores-Bellver</surname><given-names>M.</given-names></name><name><surname>Serrano-Heras</surname><given-names>G.</given-names></name><name><surname>Martinez-Gil</surname><given-names>N.</given-names></name><name><surname>Barcia</surname><given-names>J. M.</given-names></name><name><surname>Aparicio</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells.</article-title>
<source/><italic>J. Cell. Mol. Med.</italic>
<volume>20</volume>
<fpage>1457</fpage>–<lpage>1466</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.12834</pub-id>
<pub-id pub-id-type="pmid">26999719</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahrini</surname><given-names>I.</given-names></name><name><surname>Song</surname><given-names>J. H.</given-names></name><name><surname>Diez</surname><given-names>D.</given-names></name><name><surname>Hanayama</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>5</volume>:<issue>7989</issue>. <pub-id pub-id-type="doi">10.1038/srep07989</pub-id>
<pub-id pub-id-type="pmid">25612542</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>S.</given-names></name><name><surname>Polanco</surname><given-names>J. C.</given-names></name><name><surname>Gotz</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Extracellular vesicles containing P301L mutant tau accelerate pathological tau phosphorylation and oligomer formation but do not seed mature neurofibrillary tangles in ALZ17 mice.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>54</volume>
<fpage>1207</fpage>–<lpage>1217</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160371</pub-id>
<pub-id pub-id-type="pmid">27567840</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellingham</surname><given-names>S. A.</given-names></name><name><surname>Guo</surname><given-names>B. B.</given-names></name><name><surname>Coleman</surname><given-names>B. M.</given-names></name><name><surname>Hill</surname><given-names>A. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>3</volume>:<issue>124</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2012.00124</pub-id>
<pub-id pub-id-type="pmid">22563321</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>F.</given-names></name><name><surname>Pravettoni</surname><given-names>E.</given-names></name><name><surname>Colombo</surname><given-names>A.</given-names></name><name><surname>Schenk</surname><given-names>U.</given-names></name><name><surname>Möller</surname><given-names>T.</given-names></name><name><surname>Matteoli</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Astrocyte-Derived ATP induces vesicle shedding and IL-1β release from microglia.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>174</volume>:<issue>7268</issue>
<pub-id pub-id-type="doi">10.4049/jimmunol.174.11.7268</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolmont</surname><given-names>T.</given-names></name><name><surname>Haiss</surname><given-names>F.</given-names></name><name><surname>Eicke</surname><given-names>D.</given-names></name><name><surname>Radde</surname><given-names>R.</given-names></name><name><surname>Mathis</surname><given-names>C. A.</given-names></name><name><surname>Klunk</surname><given-names>W. E.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>:<issue>4283</issue>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4814-07.2008</pub-id>
<pub-id pub-id-type="pmid">18417708</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunkhorst</surname><given-names>R.</given-names></name><name><surname>Vutukuri</surname><given-names>R.</given-names></name><name><surname>Pfeilschifter</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>Fingolimod for the treatment of neurological diseases-state of play and future perspectives.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>283</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00283</pub-id>
<pub-id pub-id-type="pmid">25309325</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname><given-names>R. J.</given-names></name><name><surname>Pawlowski</surname><given-names>T.</given-names></name><name><surname>Catto</surname><given-names>J. W.</given-names></name><name><surname>Marsden</surname><given-names>G.</given-names></name><name><surname>Vessella</surname><given-names>R. L.</given-names></name><name><surname>Rhees</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Changes in circulating microRNA levels associated with prostate cancer.</article-title>
<source/><italic>Br. J. Cancer</italic>
<volume>106</volume>
<fpage>768</fpage>–<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.2011.595</pub-id>
<pub-id pub-id-type="pmid">22240788</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buller</surname><given-names>B.</given-names></name><name><surname>Moore</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Pikula</surname><given-names>E.</given-names></name><name><surname>Martin</surname><given-names>C.</given-names></name><name><surname>Mortazavi</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Exosomes from rhesus monkey MSCs promote neuronal growth and myelination.</article-title>
<source/><italic>Stroke</italic>
<volume>47</volume>:<issue>A68</issue>.</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgos</surname><given-names>K.</given-names></name><name><surname>Malenica</surname><given-names>I.</given-names></name><name><surname>Metpally</surname><given-names>R.</given-names></name><name><surname>Courtright</surname><given-names>A.</given-names></name><name><surname>Rakela</surname><given-names>B.</given-names></name><name><surname>Beach</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e94839</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0094839</pub-id>
<pub-id pub-id-type="pmid">24797360</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camussi</surname><given-names>G.</given-names></name><name><surname>Deregibus</surname><given-names>M. C.</given-names></name><name><surname>Bruno</surname><given-names>S.</given-names></name><name><surname>Grange</surname><given-names>C.</given-names></name><name><surname>Fonsato</surname><given-names>V.</given-names></name><name><surname>Tetta</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Exosome/microvesicle-mediated epigenetic reprogramming of cells.</article-title>
<source/><italic>Am. J. Cancer Res.</italic>
<volume>1</volume>
<fpage>98</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="pmid">21969178</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C. C.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>F.</given-names></name><name><surname>Wong</surname><given-names>C. W.</given-names></name><name><surname>Guo</surname><given-names>X. E.</given-names></name><name><surname>Chacko</surname><given-names>J. V.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Elucidation of exosome migration across the blood-brain barrier model in vitro.</article-title>
<source/><italic>Cell. Mol. Bioeng.</italic>
<volume>9</volume>
<fpage>509</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1007/s12195-016-0458-3</pub-id>
<pub-id pub-id-type="pmid">28392840</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Sharples</surname><given-names>R. A.</given-names></name><name><surname>Scicluna</surname><given-names>B. J.</given-names></name><name><surname>Hill</surname><given-names>A. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood.</article-title>
<source/><italic>J. Extracell Vesicles</italic>
<volume>3</volume>:<issue>23743</issue>. <pub-id pub-id-type="doi">10.3402/jev.v3.23743</pub-id>
<pub-id pub-id-type="pmid">24683445</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen-Plotkin</surname><given-names>A. S.</given-names></name><name><surname>Unger</surname><given-names>T. L.</given-names></name><name><surname>Gallagher</surname><given-names>M. D.</given-names></name><name><surname>Bill</surname><given-names>E.</given-names></name><name><surname>Kwong</surname><given-names>L. K.</given-names></name><name><surname>Volpicelli-Daley</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>11213</fpage>–<lpage>11227</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0521-12.2012</pub-id>
<pub-id pub-id-type="pmid">22895706</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chesser</surname><given-names>A. S.</given-names></name><name><surname>Pritchard</surname><given-names>S. M.</given-names></name><name><surname>Johnson</surname><given-names>G. V.</given-names></name></person-group> (<year>2013</year>). <article-title>Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease.</article-title>
<source/><italic>Front. Neurol.</italic>
<volume>4</volume>:<issue>122</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2013.00122</pub-id>
<pub-id pub-id-type="pmid">24027553</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiasserini</surname><given-names>D.</given-names></name><name><surname>van Weering</surname><given-names>J. R.</given-names></name><name><surname>Piersma</surname><given-names>S. R.</given-names></name><name><surname>Pham</surname><given-names>T. V.</given-names></name><name><surname>Malekzadeh</surname><given-names>A.</given-names></name><name><surname>Teunissen</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.</article-title>
<source/><italic>J. Proteomics</italic>
<volume>106</volume>
<fpage>191</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2014.04.028</pub-id>
<pub-id pub-id-type="pmid">24769233</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chivet</surname><given-names>M.</given-names></name><name><surname>Hemming</surname><given-names>F.</given-names></name><name><surname>Pernet-Gallay</surname><given-names>K.</given-names></name><name><surname>Fraboulet</surname><given-names>S.</given-names></name><name><surname>Sadoul</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Emerging role of neuronal exosomes in the central nervous system.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>3</volume>:<issue>145</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2012.00145</pub-id>
<pub-id pub-id-type="pmid">22654762</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>V. W.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name><name><surname>Wong</surname><given-names>P. C.</given-names></name><name><surname>Gleichmann</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>An Overview of APP Processing Enzymes and Products.</article-title>
<source/><italic>Neuromol. Med.</italic>
<volume>12</volume>
<fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/s12017-009-8104-z</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicognola</surname><given-names>C.</given-names></name><name><surname>Brinkmalm</surname><given-names>G.</given-names></name><name><surname>Wahlgren</surname><given-names>J.</given-names></name><name><surname>Portelius</surname><given-names>E.</given-names></name><name><surname>Gobom</surname><given-names>J.</given-names></name><name><surname>Cullen</surname><given-names>N. C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>137</volume>
<fpage>279</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-018-1948-2</pub-id>
<pub-id pub-id-type="pmid">30547227</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogswell</surname><given-names>J. P.</given-names></name><name><surname>Ward</surname><given-names>J.</given-names></name><name><surname>Taylor</surname><given-names>I. A.</given-names></name><name><surname>Waters</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Cannon</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>14</volume>
<fpage>27</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.3233/jad-2008-14103</pub-id>
<pub-id pub-id-type="pmid">18525125</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>M.</given-names></name><name><surname>Appleby</surname><given-names>B.</given-names></name><name><surname>Safar</surname><given-names>J. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer’s disease.</article-title>
<source/><italic>Prion</italic>
<volume>10</volume>
<fpage>9</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1080/19336896.2015.1123371</pub-id>
<pub-id pub-id-type="pmid">26809345</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>M.</given-names></name><name><surname>Raposo</surname><given-names>G.</given-names></name><name><surname>Thery</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.</article-title>
<source/><italic>Annu. Rev. Cell Dev. Biol.</italic>
<volume>30</volume>
<fpage>255</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-cellbio-101512-122326</pub-id>
<pub-id pub-id-type="pmid">25288114</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrado</surname><given-names>C.</given-names></name><name><surname>Raimondo</surname><given-names>S.</given-names></name><name><surname>Chiesi</surname><given-names>A.</given-names></name><name><surname>Ciccia</surname><given-names>F.</given-names></name><name><surname>De Leo</surname><given-names>G.</given-names></name><name><surname>Alessandro</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>14</volume>
<fpage>5338</fpage>–<lpage>5366</lpage>. <pub-id pub-id-type="doi">10.3390/ijms14035338</pub-id>
<pub-id pub-id-type="pmid">23466882</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crotti</surname><given-names>A.</given-names></name><name><surname>Sait</surname><given-names>H. R.</given-names></name><name><surname>McAvoy</surname><given-names>K. M.</given-names></name><name><surname>Estrada</surname><given-names>K.</given-names></name><name><surname>Ergun</surname><given-names>A.</given-names></name><name><surname>Szak</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>BIN1 favors the spreading of Tau via extracellular vesicles.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>9</volume>:<issue>9477</issue>. <pub-id pub-id-type="doi">10.1038/s41598-019-45676-0</pub-id>
<pub-id pub-id-type="pmid">31263146</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Mou</surname><given-names>F.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice.</article-title>
<source/><italic>FASEB J.</italic>
<volume>32</volume>
<fpage>654</fpage>–<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700600R</pub-id>
<pub-id pub-id-type="pmid">28970251</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czubowicz</surname><given-names>K.</given-names></name><name><surname>Jesko</surname><given-names>H.</given-names></name><name><surname>Wencel</surname><given-names>P.</given-names></name><name><surname>Lukiw</surname><given-names>W. J.</given-names></name><name><surname>Strosznajder</surname><given-names>R. P.</given-names></name></person-group> (<year>2019</year>). <article-title>The role of ceramide and sphingosine-1-phosphate in Alzheimer’s disease and other neurodegenerative disorders.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>56</volume>
<fpage>5436</fpage>–<lpage>5455</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-1448-3</pub-id>
<pub-id pub-id-type="pmid">30612333</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Monte</surname><given-names>S. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Insulin resistance and Alzheimer’s disease.</article-title>
<source/><italic>BMB Rep.</italic>
<volume>42</volume>
<fpage>475</fpage>–<lpage>481</lpage>. <pub-id pub-id-type="doi">10.5483/bmbrep.2009.42.8.475</pub-id>
<pub-id pub-id-type="pmid">19712582</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Monte</surname><given-names>S. M.</given-names></name><name><surname>Tong</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Brain metabolic dysfunction at the core of Alzheimer’s disease.</article-title>
<source/><italic>Biochem. Pharmacol.</italic>
<volume>88</volume>
<fpage>548</fpage>–<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2013.12.012</pub-id>
<pub-id pub-id-type="pmid">24380887</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del</surname><given-names>C. I.</given-names></name><name><surname>Shrimpton</surname><given-names>C. N.</given-names></name><name><surname>Thiagarajan</surname><given-names>P.</given-names></name><name><surname>Lopez</surname><given-names>J. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.</article-title>
<source/><italic>Blood</italic>
<volume>106</volume>
<fpage>1604</fpage>–<lpage>1611</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2004-03-1095</pub-id>
<pub-id pub-id-type="pmid">15741221</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLeo</surname><given-names>A. M.</given-names></name><name><surname>Ikezu</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Extracellular vesicle biology in Alzheimer’s disease and related tauopathy.</article-title>
<source/><italic>J. Neuroimmune Pharmacol.</italic>
<volume>13</volume>
<fpage>292</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-017-9768-z</pub-id>
<pub-id pub-id-type="pmid">29185187</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>L.</given-names></name><name><surname>Anandatheerthavarada</surname><given-names>H. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1802</volume>
<fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2009.07.007</pub-id>
<pub-id pub-id-type="pmid">19619643</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Exosomes Isolated From Human Umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer’s Disease.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>43</volume>
<fpage>2165</fpage>–<lpage>2177</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-018-2641-5</pub-id><pub-id pub-id-type="pmid">30259257</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinkins</surname><given-names>M. B.</given-names></name><name><surname>Dasgupta</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Bieberich</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>35</volume>
<fpage>1792</fpage>–<lpage>1800</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.02.012</pub-id>
<pub-id pub-id-type="pmid">24650793</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinkins</surname><given-names>M. B.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Bieberich</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>Sphingolipid-enriched extracellular vesicles and Alzheimer’s disease: a decade of research.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>60</volume>
<fpage>757</fpage>–<lpage>768</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160567</pub-id><pub-id pub-id-type="pmid">27662306</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F.</given-names></name><name><surname>Lombardi</surname><given-names>M.</given-names></name><name><surname>Prada</surname><given-names>I.</given-names></name><name><surname>Gabrielli</surname><given-names>M.</given-names></name><name><surname>Joshi</surname><given-names>P.</given-names></name><name><surname>Cojoc</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>ATP modifies the proteome of extracellular vesicles released by microglia and influences their action on astrocytes.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>8</volume>:<issue>910</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00910</pub-id>
<pub-id pub-id-type="pmid">29321741</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draznin</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin.</article-title>
<source/><italic>Diabetes</italic>
<volume>55</volume>
<fpage>2392</fpage>–<lpage>2397</lpage>. <pub-id pub-id-type="doi">10.2337/db06-0391</pub-id>
<pub-id pub-id-type="pmid">16873706</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eitan</surname><given-names>E.</given-names></name><name><surname>Hutchison</surname><given-names>E. R.</given-names></name><name><surname>Marosi</surname><given-names>K.</given-names></name><name><surname>Comotto</surname><given-names>J.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Nigam</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2016a</year>). <article-title>Extracellular vesicle-associated Aβ mediates trans-neuronal bioenergetic and Ca 2+-handling deficits in Alzheimer’s disease models.</article-title>
<source/><italic>NPJ Aging Mech. Dis.</italic>
<volume>2</volume>:<issue>16019</issue>
<pub-id pub-id-type="doi">10.1038/npjamd.2016.19</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eitan</surname><given-names>E.</given-names></name><name><surname>Suire</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>2016b</year>). <article-title>Impact of lysosome status on extracellular vesicle content and release.</article-title>
<source/><italic>Ageing Res. Rev.</italic>
<volume>32</volume>
<fpage>65</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2016.05.001</pub-id>
<pub-id pub-id-type="pmid">27238186</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmanouilidou</surname><given-names>E.</given-names></name><name><surname>Melachroinou</surname><given-names>K.</given-names></name><name><surname>Roumeliotis</surname><given-names>T.</given-names></name><name><surname>Garbis</surname><given-names>S. D.</given-names></name><name><surname>Ntzouni</surname><given-names>M.</given-names></name><name><surname>Margaritis</surname><given-names>L. H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>6838</fpage>–<lpage>6851</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5699-09.2010</pub-id>
<pub-id pub-id-type="pmid">20484626</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faure</surname><given-names>J.</given-names></name><name><surname>Lachenal</surname><given-names>G.</given-names></name><name><surname>Court</surname><given-names>M.</given-names></name><name><surname>Hirrlinger</surname><given-names>J.</given-names></name><name><surname>Chatellard-Causse</surname><given-names>C.</given-names></name><name><surname>Blot</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Exosomes are released by cultured cortical neurones.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>31</volume>
<fpage>642</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2005.12.003</pub-id>
<pub-id pub-id-type="pmid">16446100</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fevrier</surname><given-names>B.</given-names></name><name><surname>Vilette</surname><given-names>D.</given-names></name><name><surname>Archer</surname><given-names>F.</given-names></name><name><surname>Loew</surname><given-names>D.</given-names></name><name><surname>Faigle</surname><given-names>W.</given-names></name><name><surname>Vidal</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Cells release prions in association with exosomes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>9683</fpage>–<lpage>9688</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0308413101</pub-id>
<pub-id pub-id-type="pmid">15210972</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiandaca</surname><given-names>M. S.</given-names></name><name><surname>Kapogiannis</surname><given-names>D.</given-names></name><name><surname>Mapstone</surname><given-names>M.</given-names></name><name><surname>Boxer</surname><given-names>A.</given-names></name><name><surname>Eitan</surname><given-names>E.</given-names></name><name><surname>Schwartz</surname><given-names>J. B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study.</article-title>
<source/><italic>Alzheimers Dement.</italic>
<volume>11</volume>
<fpage>600</fpage>–<lpage>607.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2014.06.008</pub-id>
<pub-id pub-id-type="pmid">25130657</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fruhbeis</surname><given-names>C.</given-names></name><name><surname>Frohlich</surname><given-names>D.</given-names></name><name><surname>Kuo</surname><given-names>W. P.</given-names></name><name><surname>Amphornrat</surname><given-names>J.</given-names></name><name><surname>Thilemann</surname><given-names>S.</given-names></name><name><surname>Saab</surname><given-names>A. S.</given-names></name><etal></etal></person-group> (<year>2013a</year>). <article-title>Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication.</article-title>
<source/><italic>PLoS Biol.</italic>
<volume>11</volume>:<issue>e1001604</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1001604</pub-id>
<pub-id pub-id-type="pmid">23874151</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fruhbeis</surname><given-names>C.</given-names></name><name><surname>Frohlich</surname><given-names>D.</given-names></name><name><surname>Kuo</surname><given-names>W. P.</given-names></name><name><surname>Kramer-Albers</surname><given-names>E. M.</given-names></name></person-group> (<year>2013b</year>). <article-title>Extracellular vesicles as mediators of neuron-glia communication.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>7</volume>:<issue>182</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2013.00182</pub-id>
<pub-id pub-id-type="pmid">24194697</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatti</surname><given-names>S.</given-names></name><name><surname>Bruno</surname><given-names>S.</given-names></name><name><surname>Deregibus</surname><given-names>M. C.</given-names></name><name><surname>Sordi</surname><given-names>A.</given-names></name><name><surname>Cantaluppi</surname><given-names>V.</given-names></name><name><surname>Tetta</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.</article-title>
<source/><italic>Nephrol. Dial Transplant.</italic>
<volume>26</volume>
<fpage>1474</fpage>–<lpage>1483</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfr015</pub-id>
<pub-id pub-id-type="pmid">21324974</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geekiyanage</surname><given-names>H.</given-names></name><name><surname>Jicha</surname><given-names>G. A.</given-names></name><name><surname>Nelson</surname><given-names>P. T.</given-names></name><name><surname>Chan</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Blood serum miRNA: non-invasive biomarkers for Alzheimer’s disease.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>235</volume>
<fpage>491</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.11.026</pub-id><pub-id pub-id-type="pmid">22155483</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>J.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Diaz-Arrastia</surname><given-names>R.</given-names></name><name><surname>Lange</surname><given-names>R.</given-names></name><name><surname>Gulyani</surname><given-names>S.</given-names></name><name><surname>Diehl</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel.</article-title>
<source/><italic>Brain Inj.</italic>
<volume>32</volume>
<fpage>1277</fpage>–<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1080/02699052.2018.1471738</pub-id>
<pub-id pub-id-type="pmid">29913077</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimbel</surname><given-names>D. A.</given-names></name><name><surname>Nygaard</surname><given-names>H. B.</given-names></name><name><surname>Coffey</surname><given-names>E. E.</given-names></name><name><surname>Gunther</surname><given-names>E. C.</given-names></name><name><surname>Lauren</surname><given-names>J.</given-names></name><name><surname>Gimbel</surname><given-names>Z. A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Memory impairment in transgenic Alzheimer mice requires cellular prion protein.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>6367</fpage>–<lpage>6374</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0395-10.2010</pub-id>
<pub-id pub-id-type="pmid">20445063</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giri</surname><given-names>P. K.</given-names></name><name><surname>Kruh</surname><given-names>N. A.</given-names></name><name><surname>Dobos</surname><given-names>K. M.</given-names></name><name><surname>Schorey</surname><given-names>J. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Proteomic analysis identifies highly antigenic proteins in exosomes from <italic>M. tuberculosis</italic>−infected and culture filtrate protein−treated macrophages.</article-title>
<source/><italic>Proteomics</italic>
<volume>10</volume>
<fpage>3190</fpage>–<lpage>3202</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200900840</pub-id>
<pub-id pub-id-type="pmid">20662102</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giri</surname><given-names>P. K.</given-names></name><name><surname>Schorey</surname><given-names>J. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Exosomes derived from <italic>M. Bovis</italic> BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo.</article-title>
<source/><italic>PLoS One</italic>
<volume>3</volume>:<issue>e2461</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0002461</pub-id>
<pub-id pub-id-type="pmid">18560543</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Abner</surname><given-names>E. L.</given-names></name><name><surname>Jicha</surname><given-names>G. A.</given-names></name><name><surname>Kapogiannis</surname><given-names>D.</given-names></name><name><surname>Schwartz</surname><given-names>J. B.</given-names></name></person-group> (<year>2018</year>). <article-title>Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease.</article-title>
<source/><italic>FASEB J.</italic>
<volume>32</volume>
<fpage>888</fpage>–<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700731R</pub-id>
<pub-id pub-id-type="pmid">29025866</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Boxer</surname><given-names>A.</given-names></name><name><surname>Schwartz</surname><given-names>J. B.</given-names></name><name><surname>Abner</surname><given-names>E. L.</given-names></name><name><surname>Petersen</surname><given-names>R. C.</given-names></name><name><surname>Miller</surname><given-names>B. L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Low neural exosomal levels of cellular survival factors in Alzheimer’s disease.</article-title>
<source/><italic>Ann. Clin. Transl. Neurol.</italic>
<volume>2</volume>
<fpage>769</fpage>–<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1002/acn3.211</pub-id>
<pub-id pub-id-type="pmid">26273689</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Kapogiannis</surname><given-names>D.</given-names></name><name><surname>Schwartz</surname><given-names>J. B.</given-names></name><name><surname>Lobach</surname><given-names>I. V.</given-names></name><name><surname>Goetzl</surname><given-names>L.</given-names></name><name><surname>Abner</surname><given-names>E. L.</given-names></name><etal></etal></person-group> (<year>2016a</year>). <article-title>Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease.</article-title>
<source/><italic>FASEB J.</italic>
<volume>30</volume>
<fpage>4141</fpage>–<lpage>4148</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201600816R</pub-id>
<pub-id pub-id-type="pmid">27601437</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Kapogiannis</surname><given-names>D.</given-names></name><name><surname>Eitan</surname><given-names>E.</given-names></name><name><surname>Lobach</surname><given-names>I. V.</given-names></name><name><surname>Goetzl</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016b</year>). <article-title>Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease.</article-title>
<source/><italic>FASEB J.</italic>
<volume>30</volume>
<fpage>3853</fpage>–<lpage>3859</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201600756R</pub-id>
<pub-id pub-id-type="pmid">27511944</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Nogueras-Ortiz</surname><given-names>C.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Mullins</surname><given-names>R. J.</given-names></name><name><surname>Abner</surname><given-names>E. L.</given-names></name><name><surname>Schwartz</surname><given-names>J. B.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease.</article-title>
<source/><italic>FASEB J.</italic>
<volume>33</volume>
<fpage>231</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201801001</pub-id>
<pub-id pub-id-type="pmid">29924942</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Molina</surname><given-names>C.</given-names></name><name><surname>Sandoval</surname><given-names>M.</given-names></name><name><surname>Henzi</surname><given-names>R.</given-names></name><name><surname>Ramirez</surname><given-names>J. P.</given-names></name><name><surname>Varas-Godoy</surname><given-names>M.</given-names></name><name><surname>Luarte</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Small extracellular vesicles in rat serum contain astrocyte-derived protein biomarkers of repetitive stress.</article-title>
<source/><italic>Int. J. Neuropsychopharmacol.</italic>
<volume>22</volume>
<fpage>232</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1093/ijnp/pyy098</pub-id>
<pub-id pub-id-type="pmid">30535257</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guitart</surname><given-names>K.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><name><surname>Buck</surname><given-names>F.</given-names></name><name><surname>Bork</surname><given-names>U.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Kleene</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Improvement of neuronal cell survival by astrocyte-derived exosomes under hypoxic and ischemic conditions depends on prion protein.</article-title>
<source/><italic>Glia</italic>
<volume>64</volume>
<fpage>896</fpage>–<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22963</pub-id>
<pub-id pub-id-type="pmid">26992135</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guix</surname><given-names>F. X.</given-names></name><name><surname>Corbett</surname><given-names>G. T.</given-names></name><name><surname>Cha</surname><given-names>D. J.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Mengel</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Detection of aggregation-competent tau in neuron-derived extracellular vesicles.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>663</issue>
<pub-id pub-id-type="doi">10.3390/ijms19030663</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamlett</surname><given-names>E. D.</given-names></name><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Ledreux</surname><given-names>A.</given-names></name><name><surname>Vasilevko</surname><given-names>V.</given-names></name><name><surname>Boger</surname><given-names>H. A.</given-names></name><name><surname>LaRosa</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Neuronal exosomes reveal Alzheimer’s disease biomarkers in Down syndrome.</article-title>
<source/><italic>Alzheimers Dement.</italic>
<volume>13</volume>
<fpage>541</fpage>–<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2016.08.012</pub-id>
<pub-id pub-id-type="pmid">27755974</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamlett</surname><given-names>E. D.</given-names></name><name><surname>Ledreux</surname><given-names>A.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name><name><surname>Chial</surname><given-names>H. J.</given-names></name><name><surname>Patterson</surname><given-names>D.</given-names></name><name><surname>Espinosa</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Exosomal biomarkers in Down syndrome and Alzheimer’s disease.</article-title>
<source/><italic>Free Radic. Bio. Med.</italic>
<volume>114</volume>
<fpage>110</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.08.028</pub-id>
<pub-id pub-id-type="pmid">28882786</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Seyfried</surname><given-names>D.</given-names></name><name><surname>Meng</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Schultz</surname><given-names>L.</given-names></name><name><surname>Chopp</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Multipotent mesenchymal stromal cell–derived exosomes improve functional recovery after experimental intracerebral hemorrhage in the rat.</article-title>
<source/><italic>J. Neurosurg.</italic>
<volume>131</volume>
<fpage>290</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.3171/2018.2.JNS171475</pub-id><pub-id pub-id-type="pmid">30028267</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>A.</given-names></name><name><surname>Muth</surname><given-names>C.</given-names></name><name><surname>Dabrowski</surname><given-names>O.</given-names></name><name><surname>Krasemann</surname><given-names>S.</given-names></name><name><surname>Glatzel</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Exosomes and the prion protein: more than one truth.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>194</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00194</pub-id>
<pub-id pub-id-type="pmid">28469550</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>S. S.</given-names></name><name><surname>Wang</surname><given-names>W. X.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Nelson</surname><given-names>P. T.</given-names></name></person-group> (<year>2013</year>). <article-title>A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer’s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>35</volume>
<fpage>335</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-122350</pub-id>
<pub-id pub-id-type="pmid">23403535</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heijnen</surname><given-names>H. F.</given-names></name><name><surname>Schiel</surname><given-names>A. E.</given-names></name><name><surname>Fijnheer</surname><given-names>R.</given-names></name><name><surname>Geuze</surname><given-names>H. J.</given-names></name><name><surname>Sixma</surname><given-names>J. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.</article-title>
<source/><italic>Blood</italic>
<volume>94</volume>
<fpage>3791</fpage>–<lpage>3799</lpage>. <pub-id pub-id-type="pmid">10572093</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heisler</surname><given-names>F. F.</given-names></name><name><surname>Pechmann</surname><given-names>Y.</given-names></name><name><surname>Wieser</surname><given-names>I.</given-names></name><name><surname>Altmeppen</surname><given-names>H. C.</given-names></name><name><surname>Veenendaal</surname><given-names>L.</given-names></name><name><surname>Muhia</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Muskelin coordinates PrPC lysosome versus exosome targeting and impacts prion disease progression.</article-title>
<source/><italic>Neuron</italic>
<volume>99</volume>
<fpage>1155.</fpage>–<lpage>1169</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.010</pub-id>
<pub-id pub-id-type="pmid">30174115</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickman</surname><given-names>S. E.</given-names></name><name><surname>Allison</surname><given-names>E. K.</given-names></name><name><surname>El Khoury</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Microglial dysfunction and defective β-amyloid clearance pathways in aging alzheimer's disease mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>:<issue>8354</issue>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0616-08.2008</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation in mice.</article-title>
<source/><italic>J. Mol. Cell Biol.</italic>
<volume>2</volume>
<fpage>152</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1093/jmcb/mjq008</pub-id>
<pub-id pub-id-type="pmid">20457670</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>J. H.</given-names></name></person-group> (<year>2010</year>). <article-title>The ESCRT complexes.</article-title>
<source/><italic>Crit. Rev. Biochem. Mol. Biol.</italic>
<volume>45</volume>
<fpage>463</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.3109/10409238.2010.502516</pub-id>
<pub-id pub-id-type="pmid">20653365</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iraci</surname><given-names>N.</given-names></name><name><surname>Leonardi</surname><given-names>T.</given-names></name><name><surname>Gessler</surname><given-names>F.</given-names></name><name><surname>Vega</surname><given-names>B.</given-names></name><name><surname>Pluchino</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Focus on extracellular vesicles: physiological role and signalling properties of extracellular membrane vesicles.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>17</volume>:<issue>171</issue>. <pub-id pub-id-type="doi">10.3390/ijms17020171</pub-id>
<pub-id pub-id-type="pmid">26861302</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>R.</given-names></name><name><surname>Fasshauer</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular machines governing exocytosis of synaptic vesicles.</article-title>
<source/><italic>Nature</italic>
<volume>490</volume>
<fpage>201</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1038/nature11320</pub-id>
<pub-id pub-id-type="pmid">23060190</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>G. V.</given-names></name><name><surname>Stoothoff</surname><given-names>W. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Tau phosphorylation in neuronal cell function and dysfunction.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>117</volume>
<fpage>5721</fpage>–<lpage>5729</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.01558</pub-id>
<pub-id pub-id-type="pmid">15537830</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>R.</given-names></name><name><surname>Zuccato</surname><given-names>C.</given-names></name><name><surname>Belyaev</surname><given-names>N. D.</given-names></name><name><surname>Guest</surname><given-names>D. J.</given-names></name><name><surname>Cattaneo</surname><given-names>E.</given-names></name><name><surname>Buckley</surname><given-names>N. J.</given-names></name></person-group> (<year>2008</year>). <article-title>A microRNA-based gene dysregulation pathway in Huntington’s disease.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>29</volume>
<fpage>438</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2007.11.001</pub-id>
<pub-id pub-id-type="pmid">18082412</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>R. M.</given-names></name><name><surname>Adam</surname><given-names>M.</given-names></name><name><surname>Hammond</surname><given-names>J. R.</given-names></name><name><surname>Orr</surname><given-names>L.</given-names></name><name><surname>Turbide</surname><given-names>C.</given-names></name></person-group> (<year>1987</year>). <article-title>Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>262</volume>
<fpage>9412</fpage>–<lpage>9420</lpage>. <pub-id pub-id-type="pmid">3597417</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajimoto</surname><given-names>T.</given-names></name><name><surname>Mohamed</surname><given-names>N.</given-names></name><name><surname>Badawy</surname><given-names>S.</given-names></name><name><surname>Matovelo</surname><given-names>S. A.</given-names></name><name><surname>Hirase</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Involvement of Gbetagamma subunits of Gi protein coupled with S1P receptor on multivesicular endosomes in F-actin formation and cargo sorting into exosomes.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>293</volume>
<fpage>245</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.808733</pub-id>
<pub-id pub-id-type="pmid">29133526</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalluri</surname><given-names>R.</given-names></name><name><surname>LeBleu</surname><given-names>V. S.</given-names></name></person-group> (<year>2020</year>). <article-title>The biology, function, and biomedical applications of exosomes.</article-title>
<source/><italic>Science</italic>
<volume>367</volume>:<issue>eaau6977</issue>. <pub-id pub-id-type="doi">10.1126/science.aau6977</pub-id>
<pub-id pub-id-type="pmid">32029601</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapitein</surname><given-names>L. C.</given-names></name><name><surname>Hoogenraad</surname><given-names>C. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Building the Neuronal Microtubule Cytoskeleton.</article-title>
<source/><italic>Neuron</italic>
<volume>87</volume>
<fpage>492</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.05.046</pub-id>
<pub-id pub-id-type="pmid">26247859</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapogiannis</surname><given-names>D.</given-names></name><name><surname>Boxer</surname><given-names>A.</given-names></name><name><surname>Schwartz</surname><given-names>J. B.</given-names></name><name><surname>Abner</surname><given-names>E. L.</given-names></name><name><surname>Biragyn</surname><given-names>A.</given-names></name><name><surname>Masharani</surname><given-names>U.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease.</article-title>
<source/><italic>FASEB J.</italic>
<volume>29</volume>
<fpage>589</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1096/fj.14-262048</pub-id>
<pub-id pub-id-type="pmid">25342129</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuda</surname><given-names>T.</given-names></name><name><surname>Oki</surname><given-names>K.</given-names></name><name><surname>Ochiya</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Potential application of extracellular vesicles of human adipose tissue-derived mesenchymal stem cells in Alzheimer’s disease therapeutics.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>1212</volume>
<fpage>171</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1007/7651_2014_98</pub-id>
<pub-id pub-id-type="pmid">25085563</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawase Koga</surname><given-names>Y.</given-names></name><name><surname>Otaegi</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Different timings of Dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system.</article-title>
<source/><italic>Dev. Dyn.</italic>
<volume>238</volume>
<fpage>2800</fpage>–<lpage>2812</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.22109</pub-id>
<pub-id pub-id-type="pmid">19806666</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellett</surname><given-names>K. A.</given-names></name><name><surname>Hooper</surname><given-names>N. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Prion protein and Alzheimer disease.</article-title>
<source/><italic>Prion</italic>
<volume>3</volume>
<fpage>190</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.4161/pri.3.4.9980</pub-id><pub-id pub-id-type="pmid">19887909</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>A. H.</given-names></name><name><surname>Reimers</surname><given-names>M.</given-names></name><name><surname>Maher</surname><given-names>B.</given-names></name><name><surname>Williamson</surname><given-names>V.</given-names></name><name><surname>McMichael</surname><given-names>O.</given-names></name><name><surname>McClay</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>124</volume>
<fpage>183</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2010.07.002</pub-id>
<pub-id pub-id-type="pmid">20675101</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>B.</given-names></name><name><surname>Figueroa-Romero</surname><given-names>C.</given-names></name><name><surname>Pacut</surname><given-names>C.</given-names></name><name><surname>Backus</surname><given-names>C.</given-names></name><name><surname>Feldman</surname><given-names>E. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Insulin resistance prevents AMPK-induced Tau dephosphorylation through Akt-mediated Increase in AMPKSer-485 phosphorylation.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>290</volume>
<fpage>19146</fpage>–<lpage>19157</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.636852</pub-id>
<pub-id pub-id-type="pmid">26100639</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Nishida</surname><given-names>H.</given-names></name><name><surname>An</surname><given-names>S. Y.</given-names></name><name><surname>Shetty</surname><given-names>A. K.</given-names></name><name><surname>Bartosh</surname><given-names>T. J.</given-names></name><name><surname>Prockop</surname><given-names>D. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Chromatographically isolated CD63+ CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>170</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1522297113</pub-id>
<pub-id pub-id-type="pmid">26699510</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>H. W.</given-names></name><name><surname>Michael</surname><given-names>M. Z.</given-names></name><name><surname>Gleadle</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Hypoxic enhancement of exosome release by breast cancer cells.</article-title>
<source/><italic>BMC Cancer</italic>
<volume>12</volume>:<issue>421</issue>. <pub-id pub-id-type="doi">10.1186/1471-2407-12-421</pub-id>
<pub-id pub-id-type="pmid">22998595</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klumperman</surname><given-names>J.</given-names></name><name><surname>Raposo</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>The complex ultrastructure of the endolysosomal system.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>6</volume>:<issue>a016857</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a016857</pub-id>
<pub-id pub-id-type="pmid">24851870</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koniusz</surname><given-names>S.</given-names></name><name><surname>Andrzejewska</surname><given-names>A.</given-names></name><name><surname>Muraca</surname><given-names>M.</given-names></name><name><surname>Srivastava</surname><given-names>A. K.</given-names></name><name><surname>Janowski</surname><given-names>M.</given-names></name><name><surname>Lukomska</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Extracellular vesicles in physiology, pathology, and therapy of the immune and central nervous system, with focus on extracellular vesicles derived from mesenchymal stem cells as therapeutic tools.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>10</volume>:<issue>109</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00109</pub-id>
<pub-id pub-id-type="pmid">27199663</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowal</surname><given-names>J.</given-names></name><name><surname>Arras</surname><given-names>G.</given-names></name><name><surname>Colombo</surname><given-names>M.</given-names></name><name><surname>Jouve</surname><given-names>M.</given-names></name><name><surname>Morath</surname><given-names>J. P.</given-names></name><name><surname>Primdal-Bengtson</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>E968</fpage>–<lpage>E977</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1521230113</pub-id>
<pub-id pub-id-type="pmid">26858453</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer-Albers</surname><given-names>E. M.</given-names></name><name><surname>Bretz</surname><given-names>N.</given-names></name><name><surname>Tenzer</surname><given-names>S.</given-names></name><name><surname>Winterstein</surname><given-names>C.</given-names></name><name><surname>Mobius</surname><given-names>W.</given-names></name><name><surname>Berger</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons?</article-title>
<source/><italic>Proteomics Clin. Appl.</italic>
<volume>1</volume>
<fpage>1446</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1002/prca.200700522</pub-id>
<pub-id pub-id-type="pmid">21136642</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwano</surname><given-names>N.</given-names></name><name><surname>Kato</surname><given-names>T. A.</given-names></name><name><surname>Mitsuhashi</surname><given-names>M.</given-names></name><name><surname>Sato-Kasai</surname><given-names>M.</given-names></name><name><surname>Shimokawa</surname><given-names>N.</given-names></name><name><surname>Hayakawa</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: an exploratory pilot case-control study.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>240</volume>
<fpage>88</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2018.07.040</pub-id>
<pub-id pub-id-type="pmid">30059939</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachenal</surname><given-names>G.</given-names></name><name><surname>Pernet-Gallay</surname><given-names>K.</given-names></name><name><surname>Chivet</surname><given-names>M.</given-names></name><name><surname>Hemming</surname><given-names>F. J.</given-names></name><name><surname>Belly</surname><given-names>A.</given-names></name><name><surname>Bodon</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>46</volume>
<fpage>409</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2010.11.004</pub-id>
<pub-id pub-id-type="pmid">21111824</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>R. C.</given-names></name><name><surname>Chen</surname><given-names>T. S.</given-names></name><name><surname>Lim</surname><given-names>S. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.</article-title>
<source/><italic>Regen. Med.</italic>
<volume>6</volume>
<fpage>481</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.2217/rme.11.35</pub-id>
<pub-id pub-id-type="pmid">21749206</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>P.</given-names></name><name><surname>Frigerio</surname><given-names>C. S.</given-names></name><name><surname>De Strooper</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Variance in the identification of microRNAs deregulated in Alzheimer’s disease and possible role of lincRNAs in the pathology: the need of larger datasets.</article-title>
<source/><italic>Ageing Res. Rev.</italic>
<volume>17</volume>
<fpage>43</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2014.02.006</pub-id>
<pub-id pub-id-type="pmid">24607832</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laulagnier</surname><given-names>K.</given-names></name><name><surname>Javalet</surname><given-names>C.</given-names></name><name><surname>Hemming</surname><given-names>F. J.</given-names></name><name><surname>Chivet</surname><given-names>M.</given-names></name><name><surname>Lachenal</surname><given-names>G.</given-names></name><name><surname>Blot</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<volume>75</volume>
<fpage>757</fpage>–<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-017-2664-0</pub-id>
<pub-id pub-id-type="pmid">28956068</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B. R.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Choi</surname><given-names>E. S.</given-names></name><name><surname>Cho</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Effect of young exosomes injected in aged mice.</article-title>
<source/><italic>Int. J. Nanomed.</italic>
<volume>13</volume>
<fpage>5335</fpage>–<lpage>5345</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S170680</pub-id>
<pub-id pub-id-type="pmid">30254438</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Mankhong</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>J. H.</given-names></name></person-group> (<year>2019</year>). <article-title>Extracellular vesicle as a source of Alzheimer’s biomarkers: opportunities and challenges.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>20</volume>:<issue>E1728</issue>. <pub-id pub-id-type="doi">10.3390/ijms20071728</pub-id>
<pub-id pub-id-type="pmid">30965555</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>El</surname><given-names>A. S.</given-names></name><name><surname>Wood</surname><given-names>M. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>21</volume>
<fpage>R125</fpage>–<lpage>R134</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds317</pub-id>
<pub-id pub-id-type="pmid">22872698</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>B. D.</given-names></name><name><surname>Paine</surname><given-names>M. S.</given-names></name><name><surname>Brooks</surname><given-names>A. M.</given-names></name><name><surname>McCubrey</surname><given-names>J. A.</given-names></name><name><surname>Renegar</surname><given-names>R. H.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Senescence-associated exosome release from human prostate cancer cells.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>68</volume>
<fpage>7864</fpage>–<lpage>7871</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-6538</pub-id>
<pub-id pub-id-type="pmid">18829542</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Kaslan</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Z.</given-names></name></person-group> (<year>2017</year>). <article-title>Progress in exosome isolation techniques.</article-title>
<source/><italic>Theranostics</italic>
<volume>7</volume>
<fpage>789</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="doi">10.7150/thno.18133</pub-id>
<pub-id pub-id-type="pmid">28255367</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Bai</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Role of exosomes in central nervous system diseases.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>12</volume>:<issue>240</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2019.00240</pub-id>
<pub-id pub-id-type="pmid">31636538</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>Q.</given-names></name><name><surname>Upadhya</surname><given-names>D.</given-names></name><name><surname>Hattiangady</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>An</surname><given-names>S. Y.</given-names></name><name><surname>Shuai</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>114</volume>
<fpage>E3536</fpage>–<lpage>E3545</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1703920114</pub-id>
<pub-id pub-id-type="pmid">28396435</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lotvall</surname><given-names>J.</given-names></name><name><surname>Hill</surname><given-names>A. F.</given-names></name><name><surname>Hochberg</surname><given-names>F.</given-names></name><name><surname>Buzas</surname><given-names>E. I.</given-names></name><name><surname>Di Vizio</surname><given-names>D.</given-names></name><name><surname>Gardiner</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles.</article-title>
<source/><italic>J. Extracell Vesicles</italic>
<volume>3</volume>:<issue>26913</issue>. <pub-id pub-id-type="doi">10.3402/jev.v3.26913</pub-id>
<pub-id pub-id-type="pmid">25536934</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luarte</surname><given-names>A.</given-names></name><name><surname>Henzi</surname><given-names>R.</given-names></name><name><surname>Fernández</surname><given-names>A.</given-names></name><name><surname>Gaete</surname><given-names>D.</given-names></name><name><surname>Cisternas</surname><given-names>P.</given-names></name><name><surname>Pizarro</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Astrocyte-derived small extracellular vesicles regulate dendritic complexity through miR-26a-5p Activity.</article-title>
<source/><italic>Cells</italic>
<volume>9</volume>:<issue>930</issue>. <pub-id pub-id-type="doi">10.3390/cells9040930</pub-id>
<pub-id pub-id-type="pmid">32290095</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucey</surname><given-names>B. P.</given-names></name><name><surname>McCullough</surname><given-names>A.</given-names></name><name><surname>Landsness</surname><given-names>E. C.</given-names></name><name><surname>Toedebusch</surname><given-names>C. D.</given-names></name><name><surname>McLeland</surname><given-names>J. S.</given-names></name><name><surname>Zaza</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>11</volume>:<issue>eaau6550</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aau6550</pub-id>
<pub-id pub-id-type="pmid">30626715</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukiw</surname><given-names>W. J.</given-names></name><name><surname>Alexandrov</surname><given-names>P. N.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Hill</surname><given-names>J. M.</given-names></name><name><surname>Bhattacharjee</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Spreading of Alzheimer’s disease inflammatory signaling through soluble micro-RNA.</article-title>
<source/><italic>Neuroreport</italic>
<volume>23</volume>
<fpage>621</fpage>–<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0b013e32835542b0</pub-id>
<pub-id pub-id-type="pmid">22660168</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malla</surname><given-names>R. R.</given-names></name><name><surname>Pandrangi</surname><given-names>S.</given-names></name><name><surname>Kumari</surname><given-names>S.</given-names></name><name><surname>Gavara</surname><given-names>M. M.</given-names></name><name><surname>Badana</surname><given-names>A. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.</article-title>
<source/><italic>Asia Pac. J. Clin. Oncol.</italic>
<volume>14</volume>
<fpage>383</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1111/ajco.12869</pub-id>
<pub-id pub-id-type="pmid">29575602</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>L.</given-names></name><name><surname>Latypova</surname><given-names>X.</given-names></name><name><surname>Terro</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Post-translational modifications of tau protein: implications for Alzheimer’s disease.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>58</volume>
<fpage>458</fpage>–<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2010.12.023</pub-id><pub-id pub-id-type="pmid">21215781</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>J.</given-names></name><name><surname>Stewart</surname><given-names>T.</given-names></name><name><surname>Sheng</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Bullock</surname><given-names>K.</given-names></name><name><surname>Song</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Transmission of alpha-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease?</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>5</volume>:<issue>71</issue>. <pub-id pub-id-type="doi">10.1186/s40478-017-0470-4</pub-id>
<pub-id pub-id-type="pmid">28903781</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKelvey</surname><given-names>K. J.</given-names></name><name><surname>Powell</surname><given-names>K. L.</given-names></name><name><surname>Ashton</surname><given-names>A. W.</given-names></name><name><surname>Morris</surname><given-names>J. M.</given-names></name><name><surname>McCracken</surname><given-names>S. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Exosomes: mechanisms of uptake.</article-title>
<source/><italic>J. Circ. Biomark</italic>
<volume>4</volume>:<issue>7</issue>
<pub-id pub-id-type="doi">10.5772/61186</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Men</surname><given-names>Y.</given-names></name><name><surname>Yelick</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Chiang</surname><given-names>M.</given-names></name><name><surname>Higashimori</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Exosome reporter mice reveal the involvement of exosomes in mediating neuron to astroglia communication in the CNS.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>10</volume>:<issue>4136</issue>. <pub-id pub-id-type="doi">10.1038/s41467-019-11534-w</pub-id>
<pub-id pub-id-type="pmid">31515491</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>A. M.</given-names></name><name><surname>Lasiecka</surname><given-names>Z. M.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Neufeld</surname><given-names>J.</given-names></name><name><surname>Shahriar</surname><given-names>S.</given-names></name><name><surname>Simoes</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>291</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-02533-w</pub-id>
<pub-id pub-id-type="pmid">29348617</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momen-Heravi</surname><given-names>F.</given-names></name><name><surname>Saha</surname><given-names>B.</given-names></name><name><surname>Kodys</surname><given-names>K.</given-names></name><name><surname>Catalano</surname><given-names>D.</given-names></name><name><surname>Satishchandran</surname><given-names>A.</given-names></name><name><surname>Szabo</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.</article-title>
<source/><italic>J. Transl. Med.</italic>
<volume>13</volume>:<issue>261</issue>. <pub-id pub-id-type="doi">10.1186/s12967-015-0623-9</pub-id>
<pub-id pub-id-type="pmid">26264599</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morel</surname><given-names>L.</given-names></name><name><surname>Regan</surname><given-names>M.</given-names></name><name><surname>Higashimori</surname><given-names>H.</given-names></name><name><surname>Ng</surname><given-names>S. K.</given-names></name><name><surname>Esau</surname><given-names>C.</given-names></name><name><surname>Vidensky</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>
<fpage>7105</fpage>–<lpage>7116</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.410944</pub-id>
<pub-id pub-id-type="pmid">23364798</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>G. P.</given-names></name><name><surname>Clark</surname><given-names>I. A.</given-names></name><name><surname>Zinn</surname><given-names>R.</given-names></name><name><surname>Vissel</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research.</article-title>
<source/><italic>Neurobiol. Learn. Mem.</italic>
<volume>105</volume>
<fpage>40</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2013.07.002</pub-id>
<pub-id pub-id-type="pmid">23850597</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulcahy</surname><given-names>L. A.</given-names></name><name><surname>Pink</surname><given-names>R. C.</given-names></name><name><surname>Carter</surname><given-names>D. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Routes and mechanisms of extracellular vesicle uptake.</article-title>
<source/><italic>J. Extracell Vesicles</italic>
<volume>3</volume>:<issue>24641</issue>
<pub-id pub-id-type="doi">10.3402/jev.v3.24641</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>R. J.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Kapogiannis</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer’s disease.</article-title>
<source/><italic>Hum. Brain Mapp.</italic>
<volume>38</volume>
<fpage>1933</fpage>–<lpage>1940</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.23494</pub-id>
<pub-id pub-id-type="pmid">28105773</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngolab</surname><given-names>J.</given-names></name><name><surname>Trinh</surname><given-names>I.</given-names></name><name><surname>Rockenstein</surname><given-names>E.</given-names></name><name><surname>Mante</surname><given-names>M.</given-names></name><name><surname>Florio</surname><given-names>J.</given-names></name><name><surname>Trejo</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Brain-derived exosomes from dementia with Lewy bodies propagate alpha-synuclein pathology.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>5</volume>:<issue>46</issue>. <pub-id pub-id-type="doi">10.1186/s40478-017-0445-5</pub-id>
<pub-id pub-id-type="pmid">28599681</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ophelders</surname><given-names>D. R.</given-names></name><name><surname>Wolfs</surname><given-names>T. G.</given-names></name><name><surname>Jellema</surname><given-names>R. K.</given-names></name><name><surname>Zwanenburg</surname><given-names>A.</given-names></name><name><surname>Andriessen</surname><given-names>P.</given-names></name><name><surname>Delhaas</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia-ischemia.</article-title>
<source/><italic>Stem Cell. Transl. Med.</italic>
<volume>5</volume>
<fpage>754</fpage>–<lpage>763</lpage>. <pub-id pub-id-type="doi">10.5966/sctm.2015-0197</pub-id>
<pub-id pub-id-type="pmid">27160705</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otero-Ortega</surname><given-names>L.</given-names></name><name><surname>Gómez De Frutos</surname><given-names>M. C.</given-names></name><name><surname>Laso-García</surname><given-names>F.</given-names></name><name><surname>Rodríguez-Frutos</surname><given-names>B.</given-names></name><name><surname>Medina-Gutiérrez</surname><given-names>E.</given-names></name><name><surname>Lopez</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>38</volume>
<fpage>767</fpage>–<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X17708917</pub-id>
<pub-id pub-id-type="pmid">28524762</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Packer</surname><given-names>A. N.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Harper</surname><given-names>S. Q.</given-names></name><name><surname>Jones</surname><given-names>L.</given-names></name><name><surname>Davidson</surname><given-names>B. L.</given-names></name></person-group> (<year>2008</year>). <article-title>The bifunctional microRNA miR-9/miR-9<sup>∗</sup> regulates REST and CoREST and is downregulated in Huntington’s disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>14341</fpage>–<lpage>14346</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2390-08.2008</pub-id>
<pub-id pub-id-type="pmid">19118166</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>B. T.</given-names></name><name><surname>Johnstone</surname><given-names>R. M.</given-names></name></person-group> (<year>1983</year>). <article-title>Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor.</article-title>
<source/><italic>Cell</italic>
<volume>33</volume>
<fpage>967</fpage>–<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(83)90040-5</pub-id>
<pub-id pub-id-type="pmid">6307529</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascua-Maestro</surname><given-names>R.</given-names></name><name><surname>González</surname><given-names>E.</given-names></name><name><surname>Lillo</surname><given-names>C.</given-names></name><name><surname>Ganfornina</surname><given-names>M. D.</given-names></name><name><surname>Falcón-Pérez</surname><given-names>J. M.</given-names></name><name><surname>Sanchez</surname><given-names>D.</given-names></name></person-group> (<year>2019</year>). <article-title>Extracellular vesicles secreted by astroglial cells transport Apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>12</volume>:<issue>526</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2018.00526</pub-id>
<pub-id pub-id-type="pmid">30687015</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patz</surname><given-names>S.</given-names></name><name><surname>Trattnig</surname><given-names>C.</given-names></name><name><surname>Grunbacher</surname><given-names>G.</given-names></name><name><surname>Ebner</surname><given-names>B.</given-names></name><name><surname>Gully</surname><given-names>C.</given-names></name><name><surname>Novak</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins.</article-title>
<source/><italic>J. Neurotrauma</italic>
<volume>30</volume>
<fpage>1232</fpage>–<lpage>1242</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2012.2596</pub-id>
<pub-id pub-id-type="pmid">23360174</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perets</surname><given-names>N.</given-names></name><name><surname>Hertz</surname><given-names>S.</given-names></name><name><surname>London</surname><given-names>M.</given-names></name><name><surname>Offen</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>9</volume>:<issue>57</issue>. <pub-id pub-id-type="doi">10.1186/s13229-018-0240-6</pub-id>
<pub-id pub-id-type="pmid">30479733</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>M.</given-names></name><name><surname>Avila</surname><given-names>J.</given-names></name><name><surname>Hernandez</surname><given-names>F.</given-names></name></person-group> (<year>2019</year>). <article-title>Propagation of Tau via Extracellular Vesicles.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>13</volume>:<issue>698</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2019.00698</pub-id>
<pub-id pub-id-type="pmid">31312118</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>D. O.</given-names></name><name><surname>Jeffries</surname><given-names>C. D.</given-names></name><name><surname>Jarskog</surname><given-names>L. F.</given-names></name><name><surname>Thomson</surname><given-names>J. M.</given-names></name><name><surname>Woods</surname><given-names>K.</given-names></name><name><surname>Newman</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.</article-title>
<source/><italic>Genome Biol.</italic>
<volume>8</volume>:<issue>R27</issue>. <pub-id pub-id-type="doi">10.1186/gb-2007-8-2-r27</pub-id>
<pub-id pub-id-type="pmid">17326821</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polanco</surname><given-names>J. C.</given-names></name><name><surname>Scicluna</surname><given-names>B. J.</given-names></name><name><surname>Hill</surname><given-names>A. F.</given-names></name><name><surname>Gotz</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Extracellular vesicles isolated from the brains of rTg4510 mice seed Tau protein aggregation in a threshold-dependent manner.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>12445</fpage>–<lpage>12466</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.709485</pub-id>
<pub-id pub-id-type="pmid">27030011</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prusiner</surname><given-names>S. B.</given-names></name></person-group> (<year>1982</year>). <article-title>Novel proteinaceous infectious particles cause scrapie.</article-title>
<source/><italic>Science</italic>
<volume>216</volume>
<fpage>136</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1126/science.6801762</pub-id>
<pub-id pub-id-type="pmid">6801762</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puglielli</surname><given-names>L.</given-names></name><name><surname>Ellis</surname><given-names>B. C.</given-names></name><name><surname>Saunders</surname><given-names>A. J.</given-names></name><name><surname>Kovacs</surname><given-names>D. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>
<fpage>19777</fpage>–<lpage>19783</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M300466200</pub-id>
<pub-id pub-id-type="pmid">12649271</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raffo-Romero</surname><given-names>A.</given-names></name><name><surname>Arab</surname><given-names>T.</given-names></name><name><surname>Al-Amri</surname><given-names>I. S.</given-names></name><name><surname>Le Marrec-Croq</surname><given-names>F.</given-names></name><name><surname>Van Camp</surname><given-names>C.</given-names></name><name><surname>Lemaire</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Medicinal leech CNS as a model for exosome studies in the crosstalk between microglia and neurons.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>E4124</issue>. <pub-id pub-id-type="doi">10.3390/ijms19124124</pub-id>
<pub-id pub-id-type="pmid">30572617</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>L.</given-names></name><name><surname>Bali</surname><given-names>J.</given-names></name><name><surname>Barr</surname><given-names>M. M.</given-names></name><name><surname>Court</surname><given-names>F. A.</given-names></name><name><surname>Kramer-Albers</surname><given-names>E. M.</given-names></name><name><surname>Picou</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Emerging roles of extracellular vesicles in the nervous system.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>15482</fpage>–<lpage>15489</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3258-14.2014</pub-id>
<pub-id pub-id-type="pmid">25392515</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>L.</given-names></name><name><surname>Honsho</surname><given-names>M.</given-names></name><name><surname>Zahn</surname><given-names>T. R.</given-names></name><name><surname>Keller</surname><given-names>P.</given-names></name><name><surname>Geiger</surname><given-names>K. D.</given-names></name><name><surname>Verkade</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Alzheimer’s disease beta-amyloid peptides are released in association with exosomes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>11172</fpage>–<lpage>11177</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0603838103</pub-id>
<pub-id pub-id-type="pmid">16837572</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rak</surname><given-names>J.</given-names></name><name><surname>Guha</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Extracellular vesicles–vehicles that spread cancer genes.</article-title>
<source/><italic>Bioessays</italic>
<volume>34</volume>
<fpage>489</fpage>–<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1002/bies.201100169</pub-id>
<pub-id pub-id-type="pmid">22442051</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratajczak</surname><given-names>J.</given-names></name><name><surname>Miekus</surname><given-names>K.</given-names></name><name><surname>Kucia</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Reca</surname><given-names>R.</given-names></name><name><surname>Dvorak</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery.</article-title>
<source/><italic>Leukemia</italic>
<volume>20</volume>
<fpage>847</fpage>–<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1038/sj.leu.2404132</pub-id>
<pub-id pub-id-type="pmid">16453000</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeedi</surname><given-names>S.</given-names></name><name><surname>Israel</surname><given-names>S.</given-names></name><name><surname>Nagy</surname><given-names>C.</given-names></name><name><surname>Turecki</surname><given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>The emerging role of exosomes in mental disorders.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>9</volume>:<issue>122</issue>. <pub-id pub-id-type="doi">10.1038/s41398-019-0459-9</pub-id>
<pub-id pub-id-type="pmid">30923321</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saman</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>W.</given-names></name><name><surname>Raya</surname><given-names>M.</given-names></name><name><surname>Visnick</surname><given-names>Y.</given-names></name><name><surname>Miro</surname><given-names>S.</given-names></name><name><surname>Saman</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>3842</fpage>–<lpage>3849</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.277061</pub-id>
<pub-id pub-id-type="pmid">22057275</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saman</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>N. C.</given-names></name><name><surname>Inoyo</surname><given-names>I.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Doyle</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>40</volume>
<fpage>S47</fpage>–<lpage>S70</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-132135</pub-id>
<pub-id pub-id-type="pmid">24718102</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Covarrubias</surname><given-names>L.</given-names></name><name><surname>Slosky</surname><given-names>L. M.</given-names></name><name><surname>Thompson</surname><given-names>B. J.</given-names></name><name><surname>Davis</surname><given-names>T. P.</given-names></name><name><surname>Ronaldson</surname><given-names>P. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>20</volume>
<fpage>1422</fpage>–<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.2174/13816128113199990463</pub-id>
<pub-id pub-id-type="pmid">23789948</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santa-Maria</surname><given-names>I.</given-names></name><name><surname>Alaniz</surname><given-names>M. E.</given-names></name><name><surname>Renwick</surname><given-names>N.</given-names></name><name><surname>Cela</surname><given-names>C.</given-names></name><name><surname>Fulga</surname><given-names>T. A.</given-names></name><name><surname>Van Vactor</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>125</volume>
<fpage>681</fpage>–<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1172/JCI78421</pub-id>
<pub-id pub-id-type="pmid">25574843</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sardar</surname><given-names>S. M.</given-names></name><name><surname>Ansell-Schultz</surname><given-names>A.</given-names></name><name><surname>Civitelli</surname><given-names>L.</given-names></name><name><surname>Hildesjo</surname><given-names>C.</given-names></name><name><surname>Larsson</surname><given-names>M.</given-names></name><name><surname>Lannfelt</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>136</volume>
<fpage>41</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="pmid">29934873</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Jun</surname><given-names>S.</given-names></name><name><surname>Rellick</surname><given-names>S.</given-names></name><name><surname>Quintana</surname><given-names>D. D.</given-names></name><name><surname>Cavendish</surname><given-names>J. Z.</given-names></name><name><surname>Simpkins</surname><given-names>J. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Expression of microRNA-34a in Alzheimer’s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1646</volume>
<fpage>139</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2016.05.026</pub-id>
<pub-id pub-id-type="pmid">27235866</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawamura</surname><given-names>N.</given-names></name><name><surname>Ko</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Zou</surname><given-names>K.</given-names></name><name><surname>Hanada</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Modulation of amyloid precursor protein cleavage by cellular sphingolipids.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>11984</fpage>–<lpage>11991</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M309832200</pub-id>
<pub-id pub-id-type="pmid">14715666</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname><given-names>R. A.</given-names></name><name><surname>Sabatini</surname><given-names>D. M.</given-names></name></person-group> (<year>2017</year>). <article-title>mTOR signaling in growth, metabolism, and disease.</article-title>
<source/><italic>Cell</italic>
<volume>169</volume>
<fpage>361</fpage>–<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.03.035</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sempere</surname><given-names>L. F.</given-names></name><name><surname>Freemantle</surname><given-names>S.</given-names></name><name><surname>Pitha-Rowe</surname><given-names>I.</given-names></name><name><surname>Moss</surname><given-names>E.</given-names></name><name><surname>Dmitrovsky</surname><given-names>E.</given-names></name><name><surname>Ambros</surname><given-names>V.</given-names></name></person-group> (<year>2004</year>). <article-title>Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation.</article-title>
<source/><italic>Genome Biol.</italic>
<volume>5</volume>:<issue>R13</issue>. <pub-id pub-id-type="doi">10.1186/gb-2004-5-3-r13</pub-id>
<pub-id pub-id-type="pmid">15003116</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethi</surname><given-names>P.</given-names></name><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neocortex.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>459</volume>
<fpage>100</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.04.052</pub-id>
<pub-id pub-id-type="pmid">19406203</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Schiapparelli</surname><given-names>L.</given-names></name><name><surname>Cline</surname><given-names>H. T.</given-names></name></person-group> (<year>2013</year>). <article-title>Exosomes function in cell-cell communication during brain circuit development.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>23</volume>
<fpage>997</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2013.08.005</pub-id>
<pub-id pub-id-type="pmid">23998929</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharples</surname><given-names>R. A.</given-names></name><name><surname>Vella</surname><given-names>L. J.</given-names></name><name><surname>Nisbet</surname><given-names>R. M.</given-names></name><name><surname>Naylor</surname><given-names>R.</given-names></name><name><surname>Perez</surname><given-names>K.</given-names></name><name><surname>Barnham</surname><given-names>K. J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Inhibition of γ-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes.</article-title>
<source/><italic>FASEB J.</italic>
<volume>22</volume>
<fpage>1469</fpage>–<lpage>1478</lpage>. <pub-id pub-id-type="doi">10.1096/fj.07-9357com</pub-id>
<pub-id pub-id-type="pmid">18171695</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheinerman</surname><given-names>K. S.</given-names></name><name><surname>Tsivinsky</surname><given-names>V. G.</given-names></name><name><surname>Crawford</surname><given-names>F.</given-names></name><name><surname>Mullan</surname><given-names>M. J.</given-names></name><name><surname>Abdullah</surname><given-names>L.</given-names></name><name><surname>Umansky</surname><given-names>S. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Plasma microRNA biomarkers for detection of mild cognitive impairment.</article-title>
<source/><italic>Aging (Albany NY)</italic>
<volume>4</volume>
<fpage>590</fpage>–<lpage>605</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100486</pub-id><pub-id pub-id-type="pmid">23001356</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>M. S.</given-names></name><name><surname>Ansell-Schultz</surname><given-names>A.</given-names></name><name><surname>Civitelli</surname><given-names>L.</given-names></name><name><surname>Hildesjö</surname><given-names>C.</given-names></name><name><surname>Larsson</surname><given-names>M.</given-names></name><name><surname>Lannfelt</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>136</volume>
<fpage>41</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-018-1868-1</pub-id><pub-id pub-id-type="pmid">29934873</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skog</surname><given-names>J.</given-names></name><name><surname>Wurdinger</surname><given-names>T.</given-names></name><name><surname>van Rijn</surname><given-names>S.</given-names></name><name><surname>Meijer</surname><given-names>D. H.</given-names></name><name><surname>Gainche</surname><given-names>L.</given-names></name><name><surname>Sena-Esteves</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>10</volume>
<fpage>1470</fpage>–<lpage>1476</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1800</pub-id>
<pub-id pub-id-type="pmid">19011622</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Molecular mechanisms of neurodegeneration mediated by dysfunctional subcellular organelles in transmissible spongiform encephalopathies.</article-title>
<source/><italic>Acta Biochim. Biophys. Sin. (Shanghai)</italic>
<volume>45</volume>
<fpage>452</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmt014</pub-id>
<pub-id pub-id-type="pmid">23439666</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotiropoulos</surname><given-names>I.</given-names></name><name><surname>Galas</surname><given-names>M. C.</given-names></name><name><surname>Silva</surname><given-names>J. M.</given-names></name><name><surname>Skoulakis</surname><given-names>E.</given-names></name><name><surname>Wegmann</surname><given-names>S.</given-names></name><name><surname>Maina</surname><given-names>M. B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Atypical, non-standard functions of the microtubule associated Tau protein.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>5</volume>:<issue>91</issue>. <pub-id pub-id-type="doi">10.1186/s40478-017-0489-6</pub-id>
<pub-id pub-id-type="pmid">29187252</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuffers</surname><given-names>S.</given-names></name><name><surname>Sem</surname><given-names>W. C.</given-names></name><name><surname>Stenmark</surname><given-names>H.</given-names></name><name><surname>Brech</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Multivesicular endosome biogenesis in the absence of ESCRTs.</article-title>
<source/><italic>Traffic</italic>
<volume>10</volume>
<fpage>925</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0854.2009.00920.x</pub-id>
<pub-id pub-id-type="pmid">19490536</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Dalvi</surname><given-names>P.</given-names></name><name><surname>Abadjian</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>N.</given-names></name><name><surname>Pulliam</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV.</article-title>
<source/><italic>AIDS</italic>
<volume>31</volume>
<fpage>F9</fpage>–<lpage>F17</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000001595</pub-id><pub-id pub-id-type="pmid">28692534</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Progression of Alzheimer’s disease, tau propagation, and its modifiable risk factors.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>141</volume>
<fpage>36</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2018.08.005</pub-id>
<pub-id pub-id-type="pmid">30120962</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>A. G.</given-names></name><name><surname>Gray</surname><given-names>E.</given-names></name><name><surname>Heman-Ackah</surname><given-names>S. M.</given-names></name><name><surname>Mager</surname><given-names>I.</given-names></name><name><surname>Talbot</surname><given-names>K.</given-names></name><name><surname>Andaloussi</surname><given-names>S. E.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Extracellular vesicles in neurodegenerative disease – pathogenesis to biomarkers.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>12</volume>
<fpage>346</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2016.68</pub-id>
<pub-id pub-id-type="pmid">27174238</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmers</surname><given-names>L.</given-names></name><name><surname>Lim</surname><given-names>S. K.</given-names></name><name><surname>Hoefer</surname><given-names>I. E.</given-names></name><name><surname>Arslan</surname><given-names>F.</given-names></name><name><surname>Lai</surname><given-names>R. C.</given-names></name><name><surname>van Oorschot</surname><given-names>A. A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction.</article-title>
<source/><italic>Stem Cell Res.</italic>
<volume>6</volume>
<fpage>206</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.scr.2011.01.001</pub-id>
<pub-id pub-id-type="pmid">21419744</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trajkovic</surname><given-names>K.</given-names></name><name><surname>Hsu</surname><given-names>C.</given-names></name><name><surname>Chiantia</surname><given-names>S.</given-names></name><name><surname>Rajendran</surname><given-names>L.</given-names></name><name><surname>Wenzel</surname><given-names>D.</given-names></name><name><surname>Wieland</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Ceramide triggers budding of exosome vesicles into multivesicular endosomes.</article-title>
<source/><italic>Science</italic>
<volume>319</volume>
<fpage>1244</fpage>–<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.1126/science.1153124</pub-id>
<pub-id pub-id-type="pmid">18309083</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>P.</given-names></name><name><surname>Xiang</surname><given-names>D.</given-names></name><name><surname>Tran</surname><given-names>T.</given-names></name><name><surname>Yin</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Kong</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Exosomes and nanoengineering: a match made for precision therapeutics.</article-title>
<source/><italic>Adv. Mater.</italic>
<volume>18</volume>:<issue>e1904040</issue>. <pub-id pub-id-type="doi">10.1002/adma.201904040</pub-id>
<pub-id pub-id-type="pmid">31531916</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotta</surname><given-names>T.</given-names></name><name><surname>Panaro</surname><given-names>M. A.</given-names></name><name><surname>Cianciulli</surname><given-names>A.</given-names></name><name><surname>Mori</surname><given-names>G.</given-names></name><name><surname>Di Benedetto</surname><given-names>A.</given-names></name><name><surname>Porro</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglia-derived extracellular vesicles in Alzheimer’s Disease: a double-edged sword.</article-title>
<source/><italic>Biochem. Pharmacol.</italic>
<volume>148</volume>
<fpage>184</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2017.12.020</pub-id>
<pub-id pub-id-type="pmid">29305855</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbanelli</surname><given-names>L.</given-names></name><name><surname>Magini</surname><given-names>A.</given-names></name><name><surname>Buratta</surname><given-names>S.</given-names></name><name><surname>Brozzi</surname><given-names>A.</given-names></name><name><surname>Sagini</surname><given-names>K.</given-names></name><name><surname>Polchi</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Signaling pathways in exosomes biogenesis, secretion and fate.</article-title>
<source/><italic>Genes (Basel)</italic>
<volume>4</volume>
<fpage>152</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.3390/genes4020152</pub-id>
<pub-id pub-id-type="pmid">24705158</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valadi</surname><given-names>H.</given-names></name><name><surname>Ekstrom</surname><given-names>K.</given-names></name><name><surname>Bossios</surname><given-names>A.</given-names></name><name><surname>Sjostrand</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>J. J.</given-names></name><name><surname>Lotvall</surname><given-names>J. O.</given-names></name></person-group> (<year>2007</year>). <article-title>Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>9</volume>
<fpage>654</fpage>–<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1596</pub-id>
<pub-id pub-id-type="pmid">17486113</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Pol</surname><given-names>E.</given-names></name><name><surname>Boing</surname><given-names>A. N.</given-names></name><name><surname>Harrison</surname><given-names>P.</given-names></name><name><surname>Sturk</surname><given-names>A.</given-names></name><name><surname>Nieuwland</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Classification, functions, and clinical relevance of extracellular vesicles.</article-title>
<source/><italic>Pharmacol. Rev.</italic>
<volume>64</volume>
<fpage>676</fpage>–<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1124/pr.112.005983</pub-id>
<pub-id pub-id-type="pmid">22722893</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Giau</surname><given-names>V.</given-names></name><name><surname>An</surname><given-names>S. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer’s disease.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>360</volume>
<fpage>141</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2015.12.005</pub-id>
<pub-id pub-id-type="pmid">26723991</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Niel</surname><given-names>G.</given-names></name><name><surname>Charrin</surname><given-names>S.</given-names></name><name><surname>Simoes</surname><given-names>S.</given-names></name><name><surname>Romao</surname><given-names>M.</given-names></name><name><surname>Rochin</surname><given-names>L.</given-names></name><name><surname>Saftig</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis.</article-title>
<source/><italic>Dev. Cell</italic>
<volume>21</volume>
<fpage>708</fpage>–<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2011.08.019</pub-id>
<pub-id pub-id-type="pmid">21962903</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Niel</surname><given-names>G.</given-names></name><name><surname>D’Angelo</surname><given-names>G.</given-names></name><name><surname>Raposo</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Shedding light on the cell biology of extracellular vesicles.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>19</volume>
<fpage>213</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2017.125</pub-id><pub-id pub-id-type="pmid">29339798</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Niel</surname><given-names>G.</given-names></name><name><surname>Porto-Carreiro</surname><given-names>I.</given-names></name><name><surname>Simoes</surname><given-names>S.</given-names></name><name><surname>Raposo</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Exosomes: a common pathway for a specialized function.</article-title>
<source/><italic>J. Biochem.</italic>
<volume>140</volume>
<fpage>13</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvj128</pub-id>
<pub-id pub-id-type="pmid">16877764</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villemagne</surname><given-names>V. L.</given-names></name><name><surname>Burnham</surname><given-names>S.</given-names></name><name><surname>Bourgeat</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>B.</given-names></name><name><surname>Ellis</surname><given-names>K. A.</given-names></name><name><surname>Salvado</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>12</volume>
<fpage>357</fpage>–<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(13)70044-9</pub-id>
<pub-id pub-id-type="pmid">23477989</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Dinkins</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Poirier</surname><given-names>C.</given-names></name><name><surname>Campbell</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4) potential mechanism of apoptosis induction in Alzheimer disease (AD).</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>21384</fpage>–<lpage>21395</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.340513</pub-id>
<pub-id pub-id-type="pmid">22532571</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Balaji</surname><given-names>V.</given-names></name><name><surname>Kaniyappan</surname><given-names>S.</given-names></name><name><surname>Kruger</surname><given-names>L.</given-names></name><name><surname>Irsen</surname><given-names>S.</given-names></name><name><surname>Tepper</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The release and trans-synaptic transmission of Tau via exosomes.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>12</volume>:<issue>5</issue>. <pub-id pub-id-type="doi">10.1186/s13024-016-0143-y</pub-id>
<pub-id pub-id-type="pmid">28086931</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>L. S.</given-names></name><name><surname>Hamlett</surname><given-names>E. D.</given-names></name><name><surname>Stone</surname><given-names>T. D.</given-names></name><name><surname>Sims-Robinson</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>14</volume>:<issue>22</issue>. <pub-id pub-id-type="doi">10.1186/s13024-019-0317-5</pub-id>
<pub-id pub-id-type="pmid">31182115</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watt</surname><given-names>A. D.</given-names></name><name><surname>Perez</surname><given-names>K. A.</given-names></name><name><surname>Faux</surname><given-names>N. G.</given-names></name><name><surname>Pike</surname><given-names>K. E.</given-names></name><name><surname>Rowe</surname><given-names>C. C.</given-names></name><name><surname>Bourgeat</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Increasing the predictive accuracy of amyloid-beta blood-borne biomarkers in Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>24</volume>
<fpage>47</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-101722</pub-id>
<pub-id pub-id-type="pmid">21157020</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>R. L.</given-names></name><name><surname>Kaiser</surname><given-names>E. E.</given-names></name><name><surname>Jurgielewicz</surname><given-names>B. J.</given-names></name><name><surname>Spellicy</surname><given-names>S.</given-names></name><name><surname>Scoville</surname><given-names>S. L.</given-names></name><name><surname>Thompson</surname><given-names>T. A.</given-names></name><etal></etal></person-group> (<year>2018a</year>). <article-title>Human neural stem cell extracellular vesicles improve recovery in a porcine model of ischemic stroke.</article-title>
<source/><italic>Stroke</italic>
<volume>49</volume>
<fpage>1248</fpage>–<lpage>1256</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.117.020353</pub-id>
<pub-id pub-id-type="pmid">29650593</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>R. L.</given-names></name><name><surname>Kaiser</surname><given-names>E. E.</given-names></name><name><surname>Scoville</surname><given-names>S. L.</given-names></name><name><surname>Thompson</surname><given-names>T. A.</given-names></name><name><surname>Fatima</surname><given-names>S.</given-names></name><name><surname>Pandya</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018b</year>). <article-title>Human neural stem cell extracellular vesicles improve tissue and functional recovery in the murine thromboembolic stroke model.</article-title>
<source/><italic>Transl. Stroke Res.</italic>
<volume>9</volume>
<fpage>530</fpage>–<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1007/s12975-017-0599-2</pub-id>
<pub-id pub-id-type="pmid">29285679</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>J. A.</given-names></name><name><surname>Baxter</surname><given-names>D. H.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>D. Y.</given-names></name><name><surname>Huang</surname><given-names>K. H.</given-names></name><name><surname>Lee</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The microRNA spectrum in 12 body fluids.</article-title>
<source/><italic>Clin. Chem.</italic>
<volume>56</volume>
<fpage>1733</fpage>–<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.1373/clinchem.2010.147405</pub-id>
<pub-id pub-id-type="pmid">20847327</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>A. M.</given-names></name><name><surname>Dennahy</surname><given-names>I. S.</given-names></name><name><surname>Bhatti</surname><given-names>U. F.</given-names></name><name><surname>Halaweish</surname><given-names>I.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Chang</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Mesenchymal stem cell-derived exosomes provide neuroprotection and improve long-term neurologic outcomes in a swine model of traumatic brain injury and hemorrhagic shock.</article-title>
<source/><italic>J. Neurotraum.</italic>
<volume>36</volume>
<fpage>54</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2018.5711</pub-id>
<pub-id pub-id-type="pmid">29690826</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winston</surname><given-names>C. N.</given-names></name><name><surname>Aulston</surname><given-names>B.</given-names></name><name><surname>Rockenstein</surname><given-names>E. M.</given-names></name><name><surname>Adame</surname><given-names>A.</given-names></name><name><surname>Prikhodko</surname><given-names>O.</given-names></name><name><surname>Dave</surname><given-names>K. N.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Neuronal exosome-derived human tau is toxic to recipient mouse neurons in vivo.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>67</volume>
<fpage>541</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-180776</pub-id>
<pub-id pub-id-type="pmid">30584143</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winston</surname><given-names>C. N.</given-names></name><name><surname>Goetzl</surname><given-names>E. J.</given-names></name><name><surname>Akers</surname><given-names>J. C.</given-names></name><name><surname>Carter</surname><given-names>B. S.</given-names></name><name><surname>Rockenstein</surname><given-names>E. M.</given-names></name><name><surname>Galasko</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile.</article-title>
<source/><italic>Alzheimers Dement.</italic>
<volume>3</volume>
<fpage>63</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.dadm.2016.04.001</pub-id>
<pub-id pub-id-type="pmid">27408937</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>H. K.</given-names></name><name><surname>Veremeyko</surname><given-names>T.</given-names></name><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Lemere</surname><given-names>C. A.</given-names></name><name><surname>Walsh</surname><given-names>D. M.</given-names></name><name><surname>Esau</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer’s disease.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>3077</fpage>–<lpage>3092</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt164</pub-id>
<pub-id pub-id-type="pmid">23585551</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Jiao</surname><given-names>B.</given-names></name><name><surname>Pan</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of exosomes in the pathogenesis of Alzheimer’disease.</article-title>
<source/><italic>Transl. Neurodegener.</italic>
<volume>6</volume>:<issue>3</issue>
<pub-id pub-id-type="doi">10.1186/s40035-017-0072-x</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>R.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e89534</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0089534</pub-id>
<pub-id pub-id-type="pmid">24586853</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>H.</given-names></name><name><surname>Katakowski</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Qian</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X. S.</given-names></name><name><surname>Ali</surname><given-names>M. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>MicroRNA-17–92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats.</article-title>
<source/><italic>Stroke</italic>
<volume>48</volume>
<fpage>747</fpage>–<lpage>753</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.116.015204</pub-id>
<pub-id pub-id-type="pmid">28232590</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J. J.</given-names></name><name><surname>Zhang</surname><given-names>Z. G.</given-names></name><name><surname>Chopp</surname><given-names>M.</given-names></name></person-group> (<year>2013a</year>). <article-title>Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>33</volume>
<fpage>1711</fpage>–<lpage>1715</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2013.152</pub-id>
<pub-id pub-id-type="pmid">23963371</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Shang</surname><given-names>X.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2013b</year>). <article-title>MiR−133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome−enriched extracellular particles.</article-title>
<source/><italic>Stem Cells</italic>
<volume>31</volume>
<fpage>2737</fpage>–<lpage>2746</lpage>. <pub-id pub-id-type="doi">10.1002/stem.1409</pub-id>
<pub-id pub-id-type="pmid">23630198</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Cirrito</surname><given-names>J. R.</given-names></name><name><surname>Stewart</surname><given-names>F. R.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Finn</surname><given-names>M. B.</given-names></name><name><surname>Holmes</surname><given-names>B. B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>13110</fpage>–<lpage>13117</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2569-11.2011</pub-id>
<pub-id pub-id-type="pmid">21917794</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia.</article-title>
<source/><italic>Mol. Ther. Nucleic Acids</italic>
<volume>7</volume>
<fpage>278</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2017.04.010</pub-id>
<pub-id pub-id-type="pmid">28624203</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoi</surname><given-names>A.</given-names></name><name><surname>Villar-Prados</surname><given-names>A.</given-names></name><name><surname>Oliphint</surname><given-names>P. A.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>De Hoff</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Mechanisms of nuclear content loading to exosomes.</article-title>
<source/><italic>Sci. Adv.</italic>
<volume>5</volume>:<issue>eaax8849</issue>. <pub-id pub-id-type="doi">10.1126/sciadv.aax8849</pub-id>
<pub-id pub-id-type="pmid">31799396</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>Y.</given-names></name><name><surname>Ikezu</surname><given-names>T.</given-names></name></person-group> (<year>2019</year>). <article-title>Emerging roles of extracellular vesicles in neurodegenerative disorders.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>130</volume>:<issue>104512</issue>. <pub-id pub-id-type="doi">10.1016/j.nbd.2019.104512</pub-id>
<pub-id pub-id-type="pmid">31229685</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L. L.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J. X.</given-names></name><name><surname>Jiang</surname><given-names>F.</given-names></name><name><surname>Ni</surname><given-names>W. K.</given-names></name><name><surname>Qu</surname><given-names>L. S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A comparison of traditional and novel methods for the separation of exosomes from human samples.</article-title>
<source/><italic>Biomed. Res. Int.</italic>
<volume>2018</volume>:<issue>3634563</issue>. <pub-id pub-id-type="doi">10.1155/2018/3634563</pub-id>
<pub-id pub-id-type="pmid">30148165</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuyama</surname><given-names>K.</given-names></name><name><surname>Igarashi</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Exosomes as carriers of Alzheimer’s amyloid-ss.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>229</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00229</pub-id>
<pub-id pub-id-type="pmid">28487629</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuyama</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Mitsutake</surname><given-names>S.</given-names></name><name><surname>Igarashi</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>10977</fpage>–<lpage>10989</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.324616</pub-id>
<pub-id pub-id-type="pmid">22303002</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuyama</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Sakai</surname><given-names>S.</given-names></name><name><surname>Mitsutake</surname><given-names>S.</given-names></name><name><surname>Okada</surname><given-names>M.</given-names></name><name><surname>Tahara</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Decreased amyloid-β pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>24488</fpage>–<lpage>24498</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.577213</pub-id><pub-id pub-id-type="pmid">25037226</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuyama</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Usuki</surname><given-names>S.</given-names></name><name><surname>Sakai</surname><given-names>S.</given-names></name><name><surname>Hanamatsu</surname><given-names>H.</given-names></name><name><surname>Mioka</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A potential function for neuronal exosomes: sequestering intracerebral amyloid−β peptide.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>589</volume>
<fpage>84</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2014.11.027</pub-id><pub-id pub-id-type="pmid">25436414</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chopp</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Z. G.</given-names></name><name><surname>Katakowski</surname><given-names>M.</given-names></name><name><surname>Xin</surname><given-names>H.</given-names></name><name><surname>Qu</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>111</volume>
<fpage>69</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2016.08.003</pub-id>
<pub-id pub-id-type="pmid">27539657</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>T.</given-names></name><name><surname>Pu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Mao</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Plasma exosomes spread and cluster around β-amyloid plaques in an animal model of Alzheimer’s disease.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>9</volume>:<issue>12</issue>
<pub-id pub-id-type="doi">10.3389/fnagi.2017.00012</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Heon</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics.</article-title>
<source/><italic>Lab. Chip.</italic>
<volume>18</volume>
<fpage>1690</fpage>–<lpage>1703</lpage>. <pub-id pub-id-type="doi">10.1039/c8lc00246k</pub-id>
<pub-id pub-id-type="pmid">29780982</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>X.</given-names></name><name><surname>Xiang</surname><given-names>X.</given-names></name><name><surname>Grizzle</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Axtell</surname><given-names>R. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.</article-title>
<source/><italic>Mol. Ther.</italic>
<volume>19</volume>
<fpage>1769</fpage>–<lpage>1779</lpage>. <pub-id pub-id-type="doi">10.1038/mt.2011.164</pub-id>
<pub-id pub-id-type="pmid">21915101</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zitvogel</surname><given-names>L.</given-names></name><name><surname>Regnault</surname><given-names>A.</given-names></name><name><surname>Lozier</surname><given-names>A.</given-names></name><name><surname>Wolfers</surname><given-names>J.</given-names></name><name><surname>Flament</surname><given-names>C.</given-names></name><name><surname>Tenza</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>4</volume>
<fpage>594</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1038/nm0598-594</pub-id>
<pub-id pub-id-type="pmid">9585234</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item>
<term>α -SYN</term>
<def>
<p>α -synuclein</p>
</def>
</def-item>
<def-item>
<term>A β</term>
<def>
<p>amyloid β -protein</p>
</def>
</def-item>
<def-item>
<term>AD</term>
<def>
<p>Alzheimer’s disease</p>
</def>
</def-item>
<def-item>
<term>ALIX</term>
<def>
<p>ALG-2-interacting protein X</p>
</def>
</def-item>
<def-item>
<term>AMPA</term>
<def>
<p>α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p>
</def>
</def-item>
<def-item>
<term>Apo-E</term>
<def>
<p>apolipoprotein E</p>
</def>
</def-item>
<def-item>
<term>APP</term>
<def>
<p>amyloid precursor protein</p>
</def>
</def-item>
<def-item>
<term>ARF6</term>
<def>
<p>ADP ribosylation factor 6</p>
</def>
</def-item>
<def-item>
<term>BACE1</term>
<def>
<p>beta-secretase 1</p>
</def>
</def-item>
<def-item>
<term>BBB</term>
<def>
<p>blood brain barrier</p>
</def>
</def-item>
<def-item>
<term>BDNF</term>
<def>
<p>brain derived neurotrophic factor</p>
</def>
</def-item>
<def-item>
<term>BDEs</term>
<def>
<p>brain derived exosomes</p>
</def>
</def-item>
<def-item>
<term>BIN1</term>
<def>
<p>Bridging I Ntegrator 1</p>
</def>
</def-item>
<def-item>
<term>cAMP</term>
<def>
<p>cyclic adenosine monophosphate</p>
</def>
</def-item>
<def-item>
<term>CD</term>
<def>
<p>Cluster of differentiation</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p>central nervous system</p>
</def>
</def-item>
<def-item>
<term>CREB1</term>
<def>
<p>cAMP responsive element binding protein 1</p>
</def>
</def-item>
<def-item>
<term>CSF</term>
<def>
<p>cerebrospinal fluid</p>
</def>
</def-item>
<def-item>
<term>CT</term>
<def>
<p>computed tomography</p>
</def>
</def-item>
<def-item>
<term>ESCRT</term>
<def>
<p>the endosomal sorting complex required for transport</p>
</def>
</def-item>
<def-item>
<term>ECG</term>
<def>
<p>Electrocardiography</p>
</def>
</def-item>
<def-item>
<term>EE</term>
<def>
<p>early endosome</p>
</def>
</def-item>
<def-item>
<term>EGFR</term>
<def>
<p>epidermal growth factor receptor</p>
</def>
</def-item>
<def-item>
<term>EVs</term>
<def>
<p>extracellular vesicles</p>
</def>
</def-item>
<def-item>
<term>gDNA</term>
<def>
<p>genomic DNA</p>
</def>
</def-item>
<def-item>
<term>GAP43</term>
<def>
<p>growth associated protein 43</p>
</def>
</def-item>
<def-item>
<term>HSP</term>
<def>
<p>heat shock protein</p>
</def>
</def-item>
<def-item>
<term>IRS1</term>
<def>
<p>insulin receptor substrate 1</p>
</def>
</def-item>
<def-item>
<term>Iba1</term>
<def>
<p>ionized calcium-binding adapter molecule 1</p>
</def>
</def-item>
<def-item>
<term>IGF1</term>
<def>
<p>insulin-like growth factor 1</p>
</def>
</def-item>
<def-item>
<term>IL-1 β</term>
<def>
<p>interleukin 1 beta</p>
</def>
</def-item>
<def-item>
<term>ILVs</term>
<def>
<p>intraluminal vesicles</p>
</def>
</def-item>
<def-item>
<term>LE</term>
<def>
<p>late endosome</p>
</def>
</def-item>
<def-item>
<term>L1CAM</term>
<def>
<p>neuronal L1 cell adhesion molecule</p>
</def>
</def-item>
<def-item>
<term>LRP6</term>
<def>
<p>LDL receptor related protein</p>
</def>
</def-item>
<def-item>
<term>MCI</term>
<def>
<p>mild cognitive impairment</p>
</def>
</def-item>
<def-item>
<term>miRNA</term>
<def>
<p>micro ribonucleic acid</p>
</def>
</def-item>
<def-item>
<term>MMPs</term>
<def>
<p>matrix metalloproteinase regulators</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p>magnetic resonance imaging</p>
</def>
</def-item>
<def-item>
<term>mRNA</term>
<def>
<p>messenger ribonucleic acid</p>
</def>
</def-item>
<def-item>
<term>MS</term>
<def>
<p>multiple sclerosis</p>
</def>
</def-item>
<def-item>
<term>MSCs</term>
<def>
<p>mesenchymal stromal cells</p>
</def>
</def-item>
<def-item>
<term>MVBs</term>
<def>
<p>multivesicular bodies</p>
</def>
</def-item>
<def-item>
<term>MVEs</term>
<def>
<p>multivesicular endosomes</p>
</def>
</def-item>
<def-item>
<term>Neuro-2a</term>
<def>
<p>Murine neuroblastoma</p>
</def>
</def-item>
<def-item>
<term>nSMase2</term>
<def>
<p>neutral sphingomyelinase-2</p>
</def>
</def-item>
<def-item>
<term>NSCs</term>
<def>
<p>neural stem cells</p>
</def>
</def-item>
<def-item>
<term>NTA</term>
<def>
<p>nanoparticle tracking analysis</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>Parkinson’s disease</p>
</def>
</def-item>
<def-item>
<term>PrP</term>
<def>
<p>prion protein</p>
</def>
</def-item>
<def-item>
<term>p-S 396-tau</term>
<def>
<p>Tau phosphorylation at serine 396</p>
</def>
</def-item>
<def-item>
<term>p-T 181-tau</term>
<def>
<p>Tau phosphorylation at threonine 181</p>
</def>
</def-item>
<def-item>
<term>qPCR real-time</term>
<def>
<p>quantitative polymerase chain reaction</p>
</def>
</def-item>
<def-item>
<term>REST</term>
<def>
<p>re1 silencing transcription factor</p>
</def>
</def-item>
<def-item>
<term>S1P</term>
<def>
<p>sphingosine-1-phosphate</p>
</def>
</def-item>
<def-item>
<term>S1PR</term>
<def>
<p>S1P receptor</p>
</def>
</def-item>
<def-item>
<term>siRNA</term>
<def>
<p>small interfering ribonucleic acid</p>
</def>
</def-item>
<def-item>
<term>SMS2</term>
<def>
<p>sphingomyelin synthase 2</p>
</def>
</def-item>
<def-item>
<term>sMVBs</term>
<def>
<p>secretory multivesicular bodies</p>
</def>
</def-item>
<def-item>
<term>TGF β</term>
<def>
<p>transforming growth factor beta</p>
</def>
</def-item>
<def-item>
<term>TSG101</term>
<def>
<p>tumor susceptibility gene 101 protein.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>